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Abstract
Advances in microbial genetics have allowed discovery and assignment of function
for many genes. High-throughput transcription analysis can be conducted for
foodborne pathogens to give insight into mechanisms of adaptation and survival in
adverse conditions. With heightened knowledge of gene expression in these conditions,
steps can be taken to counteract adaptive mechanisms and inhibit growth or survival of
foodborne pathogens.
Sodium benzoate is a food antimicrobial that is commonly used in beverages and
fruit juices. A study was conducted to determine the gene expression of Escherichia coli
O157:H7 when exposed to sodium benzoate.
First, a qualitative study to determine transcription of marA, stx1, and eaeA was
undertaken using real-time reverse transcriptase polymerase chain reaction (rt-RT-PCR).
Expression of the mar operon causes increased antimicrobial resistance in bacterial
pathogens. Shiga toxin 1 (Stx1) is a well described verotoxin produced by
enterohemorrhagic E. coli (EHEC), and EaeA, or intimin, helps establish E. coli O157:H7
in the intestinal tract. For marA and stx1, rt-RT-PCR products were detected at a 1-log
greater dilution in sodium benzoate treated cells, indicating a greater level of
transcription in these cells.
Next, a microarray study was conducted to determine transcription of E. coli
O157:H7 when exposed to 0.5% sodium benzoate. Results indicate that the phosphate
specific transport (Pst) system was rapidly (within 5 min) up-regulated in response to
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sodium benzoate. This system is essential for supplying phosphate used in synthesizing
compounds such as ATP, phospholipids, and proteins. Research with Mycobacterium
smegmatis also shows that this system can serve as an efflux pump.
The urease operon was also shown to be up-regulated in E. coli O157:H7 after 60
min of exposure to sodium benzoate. Urease catalyzes the hydrolysis of urea to
ammonia and carbon dioxide, and is one mechanism by which microorganisms survive
in acidic environments. In this study, exposure of E. coli O157:H7 to sodium benzoate at
neutral pH showed increase in transcription of the entire urease operon.
These data indicate that stx1 and marA genes as well as the Pst system and urease
operon could play a role in pathogen virulence and survival when treated with sodium
benzoate.
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Chapter 1
Review of Current Literature
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Escherichia coli O157:H7
E. coli O157:H7 is a member of the enterohemorrhagic E. coli (EHEC) and causes
hemorrhagic colitis in humans. The symptoms of an E. coli O157:H7 infection generally
include severe abdominal cramps and diarrhea (often times bloody), which can lead to
death. In children under the age of five, infection can lead to a complication known as
hemolytic uremic syndrome (HUS), resulting in red blood cell destruction, renal failure,
and central nervous system complications (99). E. coli O157:H7 can cause disease at a
low infectious dose (10 - 100 cells) (86). This can be attributed to the tolerance of this
bacterium to low pH, which allows passage through the stomach and colonization in the
intestinal tract (86). E. coli O157:H7 has been linked as the causative agent in outbreaks
associated with unpasteurized apple and orange juice, and experimental data
demonstrate the tolerance of E. coli O157:H7 to acidic environments (15, 24, 88, 112).
While it is very hard to quantify the impact foodborne illnesses have in the United
States, it has been estimated that foodborne disease causes 76 million illnesses annually
and approximately 5,000 fatalities (83). There were 16,614 laboratory-confirmed cases
of foodborne illness from FoodNet participants in 2005 (~15% of the United States
population), and E. coli O157:H7 was the causative agent in 2.8% of these cases (8). The
CDC estimates that there are 73,000 cases of E. coli O157:H7 annually, leading to an
estimated 2,100 hospitalizations in the United States (20). It has been estimated that
the cost of EHEC infections was $405 million dollars in 2003 (42).
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The well-described virulence factors of E. coli O157:H7 include stx1, stx2, and
eaeA (64, 108). Shiga toxins are composed of two subunits. The B-subunit binds
glycolipids in the host, and the A-subunit inhibits protein synthesis via disruption of
ribosomal RNA (1). Shiga-toxins may cause hemorrhagic colitis, hemolytic uremic
syndrome (HUS), thrombocytopenia, hemolytic anemia, and renal failure (63). The gene
eaeA in enterohemorrhagic E. coli produces intimin, a 97-kDa protein that plays a role in
attachment onto and effacement of microvilli of the small intestine (34, 41, 71, 82, 118).

Antibiotic resistance patterns of Escherichia coli O157
The use of antimicrobial agents in food animals can promote antibiotic
resistance among both target pathogens and normal microflora. This includes
foodborne pathogens such as E. coli O157:H7, for which cattle are a known reservoir. Of
236 clinical E. coli O157:H7 isolates collected in Washington State between 1984-1991,
5.6% were resistant to streptomycin, sulfisoxazole and tetracycline (65). Among E. coli
O157:H7 clinical isolates from England and Wales in 1997, 23% were resistant to one
antibiotic and 2% were resistant to multiple antibiotics (117). Of the latter, 73% were
resistant to streptomycin, sulfonamides and tetracyclines and 14% were resistant to
sulfonamides and tetracyclines. Meng and others (87) noted a similar antibiotic trend
with resistant strains of E. coli O157:H7 isolated from humans, animals, and foods from
1984-1993. Seventy percent of the resistant isolates were resistant to streptomycin,
tetracycline, and sulfisoxazole (87). However, 19% of these isolates were resistant to

3

three or more antibiotics (87). The highest rate of antibiotic resistance was seen among
cattle isolates.
One hundred and seventy E. coli O157:H7 human isolates were received by the
Centers for Disease Control and Prevention (CDC) in 2003 (19). Of these, 10.8, 5.1, 3.2,
and 2.5% of the isolates were resistant to one, two, three and four antibiotics,
respectively (19). Tetracycline, sulfamethoxazole, and ampicillin were the antibiotics to
which resistance was the greatest, 5.7, 3.8, and 3.2%, respectively. E. coli O157:H7
isolates resistant to at least two Clinical and Laboratory Standards Institute antibiotic
subclasses increased from 3.8% in 2002 to 5.1% in 2003 (19). Streptomycin,
sulfisoxazole, and tetracycline are not routinely used to treat diarrhea in North America,
but selective pressure through the use of antibiotics in animals may select for
populations of zooinotic pathogens, such as E. coli O157:H7 (65). The mechanisms
leading to the observed multiple antibiotic phenotypes in E. coli O157:H7 are also
unclear and warrant increased attention.

Antibiotic therapy of E. coli O157 infections
Children treated with trimethoprim-sulfamethoxazole at a Montreal pediatric
hospital from 1989-1990 for E. coli O157:H7 enteritis showed no difference in the length
of shedding in stool, duration of symptoms, or the occurrence of hemolytic-uremic
syndrome (HUS) compared to control patients (104). However, patients treated with
antibiotics in that study were started on an antibiotic regimen after isolation of E. coli
O157:H7 in their stools, rather late in the course of patient illness. The use of
4

trimethoprim-sulfamethoxazole also did not increase the risk of developing HUS,
although this was a relatively small population (104).
In a prospective cohort study conducted among children infected with E. coli
O157:H7, nine patients were treated with antibiotics and 62 were not; five children
from each group developed HUS, 56 and 8%, respectively (P<0.001) (123). Of the five
children who received antibiotics and developed HUS, two received trimethoprimsulfamethoxazole, and three were administered cephalosporins. Other significant
factors were initial white blood cell count (P=0.02), with risk increasing with white blood
cell count. Time between the onset of diarrhea to the day on which the initial stool
culture was obtained also significantly affected outcome (P=0.008); risk of developing
HUS was inversely proportional to the number of days from onset of diarrhea (123). This
indicates that a rapid onset of symptoms with increased white blood cell counts gave
greater risk for HUS regardless of antibiotic treatment.
Three strains of E. coli O157:H7 (one producing Stx1, one producing Stx2, and
one producing Stx1 and Stx2) were studied for Shiga-like toxin (Stx) production when
exposed to sub-inhibitory levels of antibiotics (53). Trimethoprim and cotrimoxazole
(trimethoprim and sulfamethoxazole) stimulated Stx production in all three strains.
However, the 11 other antibiotics tested had varied effects on the release of Stx in the
three strains studied, and emphasized the differences in virulence factors that can be
seen among strains of the same pathogen.
A survey of physicians who treated the 163 case E. coli O157:H7 outbreak in
Osaka, Japan reported that 95.9% of the patients treated were given an antimicrobial
5

agent, and fosfomycin was the most commonly prescribed (126). In vitro assays
demonstrated a 7-fold increase in Stx1 production with treatment of sub-inhibitory
concentrations of fosfomycin, while none of the antibiotics tested caused an increase in
Stx2 production (126). In vivo treatment of mice infected with E. coli O157:H7 with
ciprofloxacin caused increased Stx2 production that was not observed in mice treated
with fosfomycin (128).
In another murine model, only treatment with trimethoprim-sulfamethoxazole,
caused an increase in Stx levels (68). The time of trimethoprim-sulfamethoxazole
treatment influenced the outcome of mortality. When antibiotic intervention was
initiated one day post-infection, Stx levels in blood and stool was similar to other
antibiotic treatments from which no lethality was observed. However, when the
trimethoprim-sulfamethoxazole treatment was started three days post-infection, Stx
levels in blood and stool were increased above that of the control and resulted in
increased mortality (68).

Intrinsic mechanisms of antibiotic/antimicrobial resistance
Golding and Matthews(51) described an intrinsic mechanism in E. coli O157:H7 that
results in multiple antibiotic resistance due to a mutation in the multiple antibiotic
resistance (mar) operon. Of 52 chloramphenicol-resistant E. coli O157:H7 mutants, half
were clinically resistant to tetracycline, and resistance at levels below clinical resistance
to tetracycline, nalidixic acid, and ciprofloxacin was also seen in isolates (51). The mar
operon has also been shown to contribute to multiple antibiotic resistance in Salmonella
6

Enteritidis isolates resistant to 25 ppm chlorine, 500 ppm acetic acid, 10,000 ppm
sodium benzoate, or 10,000 ppm sodium nitrite. A single exposure to acetic acid,
sodium benzoate, or nitrite induced a two- to four-fold increase in resistance to
tetracycline (103). Isolates resistant to 25 ppm chlorine showed increased resistance to
tetracycyline, chloramphenicol, and nalidixic acid, with the greatest resistance to
tetracycline and chloramphenicol (103). In both studies, susceptibility to the tested
antibiotics returned to that of the wild-type with complementation of a functional
marR, a component of the marRAB operon, suggesting that this operon was partly
responsible for the observed antibiotic resistance (51, 103).

Multiple antibiotic resistance (mar) operon
Microorganisms have adapted various intrinsic mechanisms of survival in stressful
environments. Multiple antibiotic resistance attributed to chromosomal mutations in
the mar operon was first described in Escherichia coli K12 when selecting for low levels
of tetracycline or chloramphenicol resistance (49). The susceptibility of these mutants
was decreased for the selected agent as well as other structurally unrelated antibiotics
such as penicillins, cephalosporins, puromycin, nalidixic acid, and rifampin (49, 50).
When in contact with the selective agent, resistance was induced to high levels;
however, this resistance was lost when grown in the absence of the inducing agent for
more than 100 generations (49). Resistances to the selected compounds were greatly
reduced or reversed by insertion of the composite transposon, Tn5, into the E. coli
chromosome near 34 min (1,636.7 kb), designated marA (50). Tn5-inactivated mar

7

mutants produced a truncated message of 0.7 kb, which reverses the Mar phenotype
(54). When Tn5 was excised from marA::Tn5 tetracycline sensitive mutants, the multiple
antibiotic resistance phenotype returned at a rate of 10-8 to 10-7 (50). A Mar phenotype
has been observed in Gram-negative bacteria with clinical resistance to quinolones
(122).
The mar-loci have been sequenced in E. coli K-12 and Samonella enterica serovar
Typhimurium DT104 and are present in Shigella, Klebsiella, Citrobacter, Enterobacter,
and Hafnia, indicating that this operon is highly conserved among enteric
microorganisms (25, 29, 67). MarA has been found to alter expression of more than 60
chromosomal genes of E. coli K-12 (13). The expression of MarA altered the
transcription of outer membrane proteins (e.g., OmpF, OmpX, TolC) and showed
continued overlap between the marRAB and soxRS regulons that respond to antibiotic
and oxidative stress.

Structure of the mar operon
The chromosomally mediated mar phenotype was found in mutants that
constitutively express the marRAB operon (26). The mar locus consists of two
divergently positioned transcriptional units that flank marO, marC and marRAB (26, 27).
The marO gene contains two promoters for transcription of MarC and MarRAB (Pmar I
and PmarII, respectively) (13). MarC is theorized to be a putative integral inner
membrane protein with unknown function (13). The proteins produced by the marRAB
operon are: MarR, a repressor(26, 111), MarA, an activator that is associated with
8

multiple antibiotic resistance (47, 50), and MarB, for which the function is not yet
known (80).
Increased expression of the marRAB operon will arise from mutations in marO or
marR or from inactivation of MarR when exposed to inducing agents such as salicylate
(3, 4, 27). Overexpression of marA from a multicopy plasmid resulted in a Mar
phenotype in strains where the mar locus was deleted (47).

marR
When marRAB is not induced, MarR negatively regulates the transcription of
MarA by binding to the operator, marO (111). MarR has been found to form oligomers
at two sites within marO in vitro (2, 80). Site I begins downstream of the -35
transcriptional start signal for RNA polymerase (RNAP) binding and includes 4 bp of the 10 hexamer (80). Site II begins 13 bp away from site I and ends before the transcription
start signal of marR (80). Site II has about 80% homology with site I, and site I alone was
able to repress the mar operon (80). Further research demonstrated that MarR was able
to repress the promoter by a factor of 4.3 with site I in a native form, but marO was
repressed by a factor of 20 when both sites were in their functional form (81). MarR
bound to site I could interfere with the binding of RNAP to the -35 and -10 transcription
start signals, thus blocking transcription of marRAB. MarR binding at site II may
interfere with the formation of an open complex necessary for transcription (81).
The crystalline structure of MarR reveals that it functions as a dimer, and each
monomer has a region of two -helices and three -sheets giving rise to a winged helix
9

DNA binding domain (2, 5). Footprinting studies have suggested that MarR is bound to
DNA as a dimer since about 20 bp in both strands of DNA in sites I and II of marO were
protected from digestion by DNAse (80). The 20 bp binding site of marO is centered on
a palindromic sequence TTGCCnnGGCAA (where n = any nucleotide), and in vitro when
TTGCC was transversed, all DNA binding ability was lost (81). When the two winged
binding domains (Mar-R and Mar-C) were compared among known MarR proteins, MarR was found to be highly conserved while functional regions of Mar-C were not (125).
These unconserved regions may arise from strain specific differences in marO for which
the repressor must be able to recognize (125).

marA
The accumulation of an activator, e.g. MarA, is the primary factor that controls
the expression of mar phenotype (13, 54). Of the > 60 chromosomal genes whose
expression is altered by MarA, approximately 80% increased in transcription and the
remainder were down-regulated (13). MarA is in the AraC/XylS family of transcriptional
regulators that have a helix-turn-helix DNA binding motif and are positive transcriptional
regulators (45, 46). The structurally related transcriptional activators SoxS and RobA are
also members of the AraC/XylS family and were first associated with response to
superoxide stress and organic solvents. MarA and Rob share 41 and 55% sequence
identity with SoxS, the smallest of the proteins in this trio. To different extents, all three
proteins regulate genes in the mar/sox/rob regulons. The members of this family share
a conserved region composed of 99 amino acids (carboxy terminus MarA and SoxS;
10

amino terminus Rob) that bind DNA as monomers in the promoter region and stimulate
RNAP contact and subsequent transcription (39, 46).
The region of DNA that MarA binds to is a 20 bp degenerate sequence know as a
‘marbox’ that does not indicate a preference for MarA, SoxS or RobA (77, 78). The
consensus sequence defined by Martin and others(77) (AYnGCACnnWnnRYYAAAYn;
where R = G/A, W = A/T, Y = C/T, and n = any nucleotide) is either found upstream (class
I) or overlapping (class II) the -35 signal for RNAP (78). The location and orientation of
the marbox from the -35 and -10 signals for RNAP has been found to be specific for the
promoter (77). The class I promoters (e.g. mar, acrAB, and fpr) interact with the carboxy terminal domain ( CDT) of RNAP, and their marbox is located in a reverse or
backward orientation (60, 61). In the backward orientation, MarA binds with its amino
terminus proximal to the RNAP signal(77). zwf and nfsA are class I promoters that do
not follow this pattern; their marbox is in a forward orientation and closer to the -35
RNAP signal (59, 100). Class II promoters (e.g. fumC, inaA, sodA and micF) do not
require interaction with

CDT, and their marbox is in the forward orientation and

overlaps the -35 RNAP hexamer (78).
Multiple marboxes have been identified for some promoters (e.g. micF and
zwf), that lie farther upstream of the -35 RNAP signal, but most transcriptional
activation for zwf and micF is attributed to the marbox located closest to the promoter
(38, 39, 69). It has been demonstrated in vitro that SoxS and MarA can utilize the same
marbox sequence to activate zwf transcription (glucose 6-phosphate dehydrogenase)
(60).
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Induction of the mar operon
Expression of marA can be induced by exposure to low levels of tetracycline,
chloramphenicol (49), salicylates (27, 109) , organic solvents (11), benzoate (103, 109),
chlorine, nitrite, acetic acid (103), pine oil (90), bile salts (105), spices, and various food
extracts (107). Phenolic compounds, such as salicylate, induce transcription of the mar
operon by binding to the repressor, MarR (79). Deoxycholate, a bile salt, has also been
found to bind to MarR also preventing binding to the mar operator region (105). Once
the repressor can no longer bind to the operator region, transcription of marAB is
induced.
Constitutive expression of the marRAB operon may give mutants the ability to
initially survive treatment with antibiotics and allow low-level resistance to many
antimicrobials until secondary mutations arise giving increased resistance to a specific
agent (26). Bacterial strains expressing a mar phenotype were found to be sensitive to
household disinfectants containing hydrogen peroxide, hypochlorite, alkyl dimethyl
benzyl ammonium chloride (a quaternary amine), or chloroxylenol (a phenol) (90).
Increased levels of MarA, SoxS, or RobA resulted in an increase in resistance to many
hydrophobic antibiotics, but expression of the mar/sox/rob regulon was not found to
cause resistance to hydrophilic aminoglycosides (11).

SoxRS
The SoxR is constitutively expressed and contains binuclear iron-sulfur clusters (6,
57, 124). When the iron-sulfur clusters are in an oxidized state, SoxS expression is
12

dramatically increased compared to when these clusters are in a reduced form (58).
SoxR binds equally well to the promoter of SoxS in a reduced or oxidized state, and the
oxidized state is thought to aid in the open-complex formation of RNA polymerase (33).
Like MarA, SoxS activates transcription of a number of genes in response to
superoxide and antibiotic stress (6, 58, 69, 70). Li and Demple (69) demonstrated that
purified SoxS bound near the promoter region of genes under control of the soxRS
regulon (e.g. micF, nfo, zwf, and sodA) and increased the transcription of these genes.
SoxS was shown to bind in vitro to a region adjacent to or overlapping the -35 RNAP
signal of zwf, sodA, nfo, micF, and fumC (38). The superoxide generating herbicide,
paraquat, induced soxS expression and caused transcription of sodA and micF (102).
Disruption of sodA caused increased sensitivity to cells treated with paraquat (102).

Rob
SoxS and MarA are very similar to the amino terminus of the Rob protein that is
known to bind to the right arm of the origin of replication, oriC (10, 113). Rob is located
at 99.8 min on the E. coli K-12 chromosome and also has a helix-turn-helix motif found
in MarA and SoxS (113). Unlike MarA and SoxS, Rob is constitutively expressed to fulfill
an unknown purpose. Rob has been reported at levels of 5000 and 1000 molecules per
cell for stationary and log phase cells, respectively (62, 113).
Overexpression of Rob resulted in increased resistance to multiple antibiotics
and superoxide generating agents (10). Rob activated the transcription of zwf, fumC,
micF, nfo and sodA by binding to the marbox region and interacted with the promoters
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of the affected genes similarly to SoxS and MarA (61). Rob had the same affinity for
binding micF promoter as oriC and bound more weakly to the promoters of sodA, nfo
and zwf (10).

Overlaping Regulation by MarA, SoxS and RobA
Although MarA, SoxS and RobA can regulate the same promoters that respond to
multiple antibiotic and superoxide resistance, each protein activates promoters to
different extents. The marbox is very important in activator discrimination of
promoters. Martin and others (78) found that differences in the marboxes versus the
core promoters were the principal factors involved in activator discrimination.
Martin and others (78) demonstrated that overproduction of SoxS in marRAB
and soxRS deleted strains led to greater superoxide resistance than overproduction of
MarA; however, both MarA and SoxS were equally effective in promoting antibiotic
resistance. MarA was also shown to increase transcription of seven proteins that were
unaffected by SoxS (52). Levels of organic solvent tolerance were reduced in wild type
and Mar mutants when only SoxS was present (119). Overproduction of SoxS causes
greater superoxide and antibiotic resistance than does overproduction of RobA (10).
Overexpression of SoxS results in greater transcription of fumC, sodA, and inaA when
compared to RobA, and RobA does not stimulate transcription of zwf (10).
When the marbox from the mar promoter was substituted for the native zwf
marbox, MarA transcriptional activation increased relative to that of SoxS (78). When
the micF promoter marbox was replaced for that of fpr, SoxS transcriptional activation
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was increased compared to that of MarA (78). The position of the marbox relative to
the promoter (i.e., class I versus class II) has not been shown to be a discriminating
factor for activators (78). Promoter discrimination allows for specialized transcriptional
activation of MarA, SoxS and RobA. Minute differences between these activators can
result in different affinities and interactions with promoter marboxes resulting in varied
regulation of many genes within the mar/sox/rob regulon.

Genes induced by Mar, Sox, and Rob

acrAB
AcrAB is part of a multi-drug efflux system, AcrAB-TolC. AcrA is a periplasmic
lipoprotein that spans the periplasmic space between the inner membrane, where its
amino terminus is anchored, and outer membrane proteins (48). AcrA is also a member
of the membrane-fusion protein (MFP) family (48). AcrB is a putative pump and a
member of the resistance-nodulation-division (RND) family (48).
AcrAB expression is under control of MarA and AcrR (72, 96). In both wild-type
and Mar mutants, where the acrAB locus was deleted, hyper-susceptibility to antibiotics
and organic solvents occurred to the same extent (90, 96, 119). Active efflux of harmful
compounds has been shown to be a resistance mechanism that results in multiple
antibiotic resistance (14). AcrAB production causes an intrinsic level of resistance that is
increased in mar mutants (73, 96).
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tolC
TolC is an outer membrane porin that is part of the AcrAB-TolC efflux system (40).
TolC has been shown to be positively regulated by MarA, SoxS, and RobA (9, 13).
Increased resistance to organic solvents has been attributed to increased levels of the
TolC outer membrane protein and the AcrA inner membrane protein (9). A defective
tolC gene results in increased sensitivity to organic solvents, and TolC is required for the
expression of the Mar phenotype (9, 40).

micF
micF encodes an antisense RNA regulator of outer membrane protein F (OmpF),
which serves as a passage for hydrophilic substances (95). The mRNA product of micF
has a long sequence that is complementary to the 5’ end region of ompF mRNA. OmpF
and OmpC are the two major outer membrane porins of E. coli K-12 (95). Limiting OmpF
has been shown to occur in E. coli K-12 expressing a Mar phenotype, and cells devoid of
a micF locus were unable to cause a reduction in OmpF (13, 28). MarA has been shown
to increase expression of micF, causing a decrease in ompF mRNA that is available to
undergo translation (13, 28).

zwf, fumC, and sodA
Many proteins are involved in protection of the cell from oxidative stress and are
positively controlled by the mar/sox/rob regulons (60, 61, 69, 93, 102). zwf (glucose 6phosphate dehydrogenase) generates NADPH that supplies reducing capability for
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antioxidant enzymes (e.g., glutathione reductase and alkylhydroperoxide reductase) (32,
43). fumC is heat-stable fumarase that replaces superoxide sensitive fumarases A and B
that are inactivated by superoxide radicals (32, 43). sodA (manganese superoxide
dismutase) scavanges O2.- (superoxide) and hydrogen peroxide, thereby retarding
oxidative damage (32).

inaA
InaA is a weak-acid inducible protein, and the membrane-permeant acids that
induce inaA have the ability to lower the internal pH of the cell or act as uncouplers of
oxidative phosphorylation (106). Non-dissociating analogs of benzoate and salicylate
(benzyl and salicyl alcohol) were unable to induce expression of inaA (120). inaA maps
to 48.6 min on the E. coli K-12 chromosome and has been shown to be positively
regulated by SoxS and MarA (110, 120). Expression of MarA is responsible for 20-50% of
the basal expression of inaA, and mar deleted strains contained 30-50% less InaA when
compared to mar strains induced with paraquat (110).

nfsA
nfsA (formerly mdaA) encodes a major oxygen-insensitive nitroreductase that is a
flavoprotein in Escherichia coli which catalyzes the reduction of nitroaromatic and
nitroheterocyclic compounds by the transfer of two electrons from NADPH (100). nsfA
has been mapped to 19.2 min on the E. coli K-12 chromosome (127). nsfA has been
shown to be expressed under positive regulation of MarA and SoxS (13, 31, 70). A gene
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of unknown function, ybjC, is expressed by MarA and SoxS in a similar manner, and
these two genes may form an operon (13, 31). The marbox for nfsA is a class I promoter
in forward orientation (100).

Escherichia coli O157:H7 Urease Operon
Escherichia coli O157:H7 is known to produce urea when degrading arginine to
putrescine (91, 92). Urease (EC 3.5.1.5) catalyzes the reaction of urea into two
molecules of ammonia and carbon dioxide (89). The liberated ammonia results in
increased pH of the surrounding environment. Escherichia coli O157:H7 EDL933
genomic sequence contains an O-island with two urease gene clusters (ureDABCEFG)
(101). Urease is composed of three structural proteins, UreA, UreB, and UreC, as well as
four accessory proteins, UreD, UreE, UreF, and UreG (89). This enzyme could give
enterohemorrhagic E. coli (EHEC) the ability to neutralize acidic environments and allow
for survival in acidic food products as well as support survival in the gastrointestinal
tract.
When studying the presence of the urease gene clusters in E. coli O157:H7
isolates, it was found that among serotype O157:H7 isolates (n= 59), 98% contained all
genes in the urease operon(44). In contrast, none of the genes in the urease operon
were present in sorbitol-fermenting O157:NM (non-motile) isolates (n=82) (44).
However, among O157:H7 isolates found to have the urease operon, only one was
found to have urease activity when evaluated with Christensen’s agar or with the API
20E system; in this isolate, elevated levels of ammonia were detected (44). When
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evaluating nine isolates of serotype O55:H7, from which E. coli O157:H7 has been
theorized to have diverged, none contained genes in the urease operon (44).
Similarly, Orth et al. (97) studied the distribution of ureC among 202 EHEC that
encompassed 61 serotypes. It was found that all O157:H7 and O157:NM (n=72) that
displayed the typical non-sorbitol fermenting phenotype possessed the ureC gene (97).
However, all sorbitol fermenting O157:NM isolates (n=8) were negative for ureC (97).
All isolates containing ureC were also found to contain all genes in the urease operon
(97). When the ureC isolates were evaluated for urease production in urease
degradation broth, only 3.4% showed urease activity (97). The nucleotide sequence of
all urease genes present in ten O157:H7 isolates studied were found to have ≥ 99%
homology (97). These data indicate that the urease operon was acquired by O157:H7
relatively recently and possibly through horizontal gene transfer or gene loss since both
O55:H7 and sorbitol fermenting O157:NM strains lack the urease gene cluster, and
although many E. coli O157:H7 isolates contain the urease operon, it is not commonly
expressed under normal culture conditions.
Nakano et al. (94) examined urease production by E. coli O157:H7 Sakai in
various culture media, pH, temperatures, and nutrients via ammonia production
without any success at stimulating urease production. When further examining 120
EHEC isolates for urease activity, two isolates were identified as being urease positive
(94). All isolates were determined to have a urease operon of similar size (4940 bp), and
the nucleotide sequence was similar for a urease positive strain compared to the Sakai
strain except for a slightly longer open reading frame in the ureD gene of the urease
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positive isolate (94). It was revealed that the Sakai strain as well as all urease negative
EHEC isolates examined (n=158) had a premature stop codon for ureD compared to that
of the urease negative isolate. When the ureD gene of a urease positive EHEC was
transformed into the Sakai strain urease production was detected (94). These data
indicate that the premature stop codon in UreD plays a role in urease production in
vitro.
When attempting to stimulate urease production in E. coli O157:H7 strain
EDL933, urease could not be detected using Christensen’s agar, enzymatic assays, or
immunoblotting techniques targeting UreC and UreD (56). However, when nonpathogenic E. coli DH5 was transformed with the EHEC ure gene cluster, urease was
detected via enzymatic activity (56). This demonstrated that the urease genes present
in the EDL933 strain were functional, but failed to be expressed under multiple culture
conditions. It is interesting that the ureD nucleotide sequence in strain EDL933 is
identical to Sakai (94). When Nakano et al.(94) transformed the Sakai ureD gene into E.
coli DH5 , urease was detected. The authors believe that the amber suppressor
phenotype of DH5 played a role in read-through of the premature stop codon. Heimer
et al. (56) determined that a trans-acting factor was inhibiting urease transcription in
EHEC. These authors also identified three Fur-like (ferric-uptake regulator) recognition
sites upstream of ureA and ureD (56). In this study, urease production was detected in
two other EHEC strains (IN1 and MO28), and a Δfur background greatly diminished the
urease activity of these strains (56). This research indicated that Fur, as well as other
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unidentified trans-acting factors, plays a role in regulating the expression of urease in
EHEC.

Phosphate Specific Transport (Pst) of E. coli
The acquisition of phosphorus is essential for bacteria to supply energy and
synthesize DNA, RNA, lipopolysaccharides, and phospholipids. Microorganisms must
transport inorganic phosphorus (Pi) into the cytoplasm in order to survive. The first step
in this process for E. coli is to transport organic and inorganic forms of phosphorus
across the cell wall. In E. coli there are two common pore-forming proteins, OmpC and
OmpF. However, under phosphate limited situations, a third anion binding porin, PhoE,
is expressed in order to sequester phosphorus into the periplasm (98).
The Pst system is in the ATP binding cassette (ABC) superfamily of transporters
and is one mechanism of transporting Pi across the cell membrane. This system is
known to be expressed when Pi concentration is below 0.001 M (116). This system has a
high affinity for binding of phosphate and is composed of four proteins, PstS, PstC, PstA,
and PstB (116). The gene pstS (formerly phoS) encodes a phosphate binding protein
that binds Pi in the periplasmic space where it can be transported across the cell
membrane (84, 85, 121). PstC and PstA are transmembrane proteins that form a
passage across the cell membrane (30), while PstB catalyzes the movement of
phosphorus into the cytoplasm by hydrolysis of ATP (22).
PhoR and PhoB regulate the Pho regulon, for which the Pst system is a member.
PhoR is a transmembrane signal transduction protein that senses low levels of Pi in the
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periplasm. PhoR has an extracellular sensory domain and an intracellular signaling
domain(114). Under phosphate limited conditions, PhoR undergoes
autophosphorylation and acts as a histidine kinase that phosphorylates PhoB (75, 76).
Once PhoB is activated, it will begin to stimulate the Pho regulon by binding to the ‘Pho
box’ consensus sequence stimulating transcription of pstS (74, 75). In addition to
pstSCAB, PhoB also regulates the expression of PhoA, which is a periplasmic alkaline
phosphatase that will free Pi from phosphate containing compounds so it is available for
uptake into the cytoplasm. PhoU is a 21 KDa cytoplasmic protein that is necessary for
repression of the Pho regulon (7, 76). Repression occurs when PhoU acts to promote
dephosphorylation of PhoB, thus inactivating this protein (114).
A role other than phosphate transport has been determined for the Pst system in
Mycobacterium smegmatis. A M. smegmatis strain which was resistant to ciprofloxacin
was found to over-express the Pst operon when grown in sufficient quantities of
phosphorus (12, 16, 21). The pstB gene was also shown to have increased amplification
on the chromosome of the M. smegmatis ciprofloxacin resistant strain(21). When the
pstB gene was mutated, the minimum inhibitory concentration of M. smegmatis to
ciprofloxacin was greatly reduced (12). It was also demonstrated that the ciprofloxacin
resistant strain had a much greater efflux of this fluoroquinolone from the cell
compared to that of the wild type or pstB mutant (12). The fluoroquinolone resistant
M. smegmatis strain showed increased phosphate uptake that was diminished along
with ciprofloxacin resistance when pstB was mutated (16). These results indicate that
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the Pst system serves as an efflux mechanism of fluoroquinolone for M. smegmatis in
addition to the traditional role as a high-affinity transporter of phosphorus.

Sodium Benzoate
Sodium benzoate is a food additive commonly used in acidic beverages due to its
relatively low pKa (4.2) and increased solubility (compared to benzoic acid). This
compound is generally recognized as safe and may be added at concentrations up to
0.1% in foods (21 CFR 184.1733).

Proposed Mechanisms of Microbial and Fungal Inhibition with Weak Acids
A general mechanism of inhibition for weak acids starts with diffusion of the
undissociated compound through the plasma membrane by passive diffusion. Once
inside the cell, the higher pH causes dissociation of the acid and lower intracellular pHi
and inhibition of membrane-bound transport (18). Eklund (35) determined that uptake
inhibition contributed to growth inhibition, but did not seem to completely explain this
phenomenon. Eklund (37) found that ΔpH (pH difference) was eliminated by sorbic acid
as well as methyl and butyl paraben, whereas the membrane potential (Δψ) was
maintained (37). This indicates more than simple inhibition of the proton motive force,
since the membrane potential maintained would allow for uptake of essential
compounds for cellular maintenance.
It has been determined that dissociated weak acids also contribute slightly to
growth inhibition, which cannot be explained by the effects of pH i (36). Sorbic acid,
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sorbic alcohol, and sorbic aldehyde have been found to cause similar levels of inhibition,
demonstrating a mechanism of inhibition other than a weak acid effect (115).
Bracey et al. (17) found that pHi was not altered in Saccharomyces cerevisiae
exposed to sorbic acid. However, a higher ADP/ATP ratio was found, indicating that the
cell was expending energy to maintain pHi (17), and this expenditure of ATP was
theorized to decrease cellular growth. Membrane disruption has also been attributed
as a mechanism of inhibition by weak acids (17, 115). Krebs and et al. (66) observed a
reduction in phosphofructokinase activity in Saccharomyces cerevisiae when exposed to
benzoate (66). The disruption of glycolysis was thought to be caused by a decrease in
pHi that decreased the enzymatic activity of phosphofructokinase.Nitrogen starvation
and benzoic acid treatment inhibit growth of Saccharomyces cerevisiae. However, when
used in combination, they are cytocidal (55). It was found that benzoic acid inhibited
the break-down of cytosolic compounds to form amino acids and nucleotides necessary
for growth and survival (55).
Some microorganisms contain pathways to degrade weak acids. Benzoate is
degraded in microorganisms via the -ketoadipate pathway resulting in acyl CoA and
succinic acid (23). These degradation pathways serve as innate responses to weak acid
resistance.
The following chapters of this dissertation will discuss the transcriptional
response of Escherichia coli O157:H7 when exposed to sodium benzoate. This will help
determine some of the primary mechanisms by which E. coli responds and survives this
stressful environment. It is essential to identify and understand these mechanisms, so
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that methods can be developed by the food industry to inhibit or control the survival of
this pathogen in foods.
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Chapter 2
Transcription Analysis of stx1, marA, and eaeA Genes in
Escherichia coli O157:H7 Exposed to Sodium Benzoate
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Abstract
Expression of the multiple antibiotic resistance (mar) operon causes increased
antimicrobial resistance in bacterial pathogens. The activator of this operon, MarA, can
alter expression of >60 genes in E. coli K12. However, data are lacking concerning the
expression of virulence and resistance genes when foodborne pathogens are exposed to
antimicrobial agents. This study was conducted to determine transcription of marA (mar
activator), stx1A (Shiga toxin 1), and eaeA (intimin) genes of E. coli O157:H7 EDL933 as
affected by sodium benzoate. E. coli O157:H7 was grown in Luria-Bertani broth (LB)
containing 0 (control) and 1% sodium benzoate at 37°C for 24 h, and total RNA was
extracted. Primers were designed for hemX (209 bp; housekeeping gene), marA (261
bp), and eaeA (223 bp) genes; previously reported primers were used for stx1. Ten-fold
dilutions of RNA were used in a real-time one-step reverse-transcriptase polymerase
chain reaction (rt-RT-PCR) to determine transcription levels. All experiments were
conducted in triplicate and product detection was validated by gel electrophoresis. For
marA and stx1, rt-RT-PCR products were detected at a 1-log greater dilution in sodium
benzoate treated cells than control cells, although cell numbers for each were similar
(7.28 and 7.57 log CFU/ml, respectively). This indicates a greater (albeit slight) level of
their transcription in the treated as compared to control cells. No difference in
expression in the eaeA gene was observed. HemX is a putative uroporphyrinogen III
methylase. The hemX gene had the same level of expression in control and treated cells,
validating hemX as an appropriate housekeeping marker. These data indicate that stx1
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and marA genes could play a role in pathogen virulence and survival when treated with
sodium benzoate, while eaeA expression is not altered. Understanding adaptations of E.
coli O157:H7 during antimicrobial exposure is essential to better understand and
implement methods to inhibit or control survival of this pathogen in foods.
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Introduction
The impact of foodborne illnesses are very hard to quantify. However, it has
been estimated that foodborne diseases cause 76 million illnesses and 325,000
hospitalizations in the U.S. annually (29). Escherichia coli O157:H7 alone causes an
estimated 73,000 cases of foodborne illness annually with a 0.29% hospitalization rate
(29). The Foodborne Diseases Active Surveillance Network (FoodNet) of the Centers for
Disease Control and Prevention (CDC) Emerging Infections Program collects data from
10 states, which represents approximately 15% of the United States population. In
2005, 16,614 cases of foodborne illness were reported, and E. coli O157 was linked as
the causative agent in 2.8% of these cases (41).
Understanding survival of E. coli O157:H7 in the environment during exposure to
stressful conditions is necessary in order to apply efficacious decontamination and
control strategies. Microorganisms manifest various intrinsic mechanisms for survival in
stressful environments. Multiple antibiotic resistance attributed to chromosomal
mutations in the mar operon (multiple antibiotic resistance) was first described in
Escherichia coli K12 when selecting for low levels of tetracycline or chloramphenicol
resistance (17). The mar-loci are present in E. coli K-12, Salmonella, Shigella, Klebsiella,
Citrobacter, Enterobacter, and Hafnia, indicating that this operon is highly conserved
among enteric microorganisms (7, 10, 24).
The chromosomally mediated mar phenotype was found in mutants that
constitutively express the marRAB operon (8). The mar locus consists of two divergently
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positioned transcriptional units that flank marO: marC and marRAB. The proteins
produced by the marRAB operon are: MarR, a repressor (8, 38); MarA, an activator that
is associated with multiple antibiotic resistance (16, 18); and MarB, for which the
function is not yet known (27).
The accumulation of MarA is the primary factor that controls expression of the
mar phenotype (3, 19). MarA has been found to alter expression of more than 60
chromosomal genes; approximately 80% of these increased in transcription, and the
remainder were down-regulated in E. coli K-12 (3). The expression of MarA altered the
transcription of outer membrane proteins (e.g., OmpF, OmpX, OmpC) and increased
expression of multi-drug efflux systems. MarA transcriptional regulator has a region
composed of 99 amino acids that bind DNA as monomers in the promoter region and
stimulate RNA polymerase contact and subsequent transcription (13, 15).
Constitutive expression of the marRAB operon may give microorganisms the
ability to initially survive treatment with antibiotics and allow low-level resistance to
many antimicrobials until secondary mutations arise giving increased resistance to a
specific agent (8). Also, the increase in ability of the organism to survive may increase
its virulence and/or vice versa.
The well-described virulence factors of E. coli O157:H7 include stx1 and eaeA
(22, 36). Shiga toxin, stx1, is composed of two subunits. The B-subunit binds glycolipids
in the host, and the A-subunit inhibits protein synthesis via disruption of ribosomal RNA
(1). Shiga-toxins may cause hemorrhagic colitis, hemolytic uremic syndrome (HUS),
thrombocytopenia, hemolytic anemia, and renal failure (21). The gene eaeA in
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enterohemorrhagic E. coli produces intimin, a 97-kDa protein that plays a role in
attachment onto and effacement of microvilli of the intestine (11, 14, 26, 28, 40).
Sodium benzoate is a food additive commonly used in acidic beverages due to its
relatively low pka (4.2) and increased solubility (compared to benzoic acid). This
compound is generally recognized as safe and may be added at concentrations up to
0.1% in foods (21CFR184.1733). A general mechanism of microbial inhibition for weakacids, such as benzoic acid, starts with passive diffusion of the undissociated compound
through the plasma membrane. Once inside the cell, the neutral internal pH causes
dissociation of the acid, reduction in intracellular pHi, and inhibition of membranebound transport (5). E. coli O157:H7 has been linked as the causative agent in outbreaks
associated with unpasteurized apple and orange juice, and experimental data
demonstrate the tolerance of E. coli O157:H7 to acidic environments (4, 6, 30, 39).
Expression of the marA gene and the transcriptional response of two virulence
factors, stx1 and eaeA, were investigated to determine the effects of sodium benzoate
exposure. It was the goal of this research to compare expression of stx1, eaeA, and
marA genes of control E. coli O157:H7 (untreated) and E. coli O157:H7 strain EDL933
exposed to 1% sodium benzoate.
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Materials and Methods
Growth of Escherichia coli O157:H7
Escherichia coli O157:H7 strain EDL 933 (genome fully sequenced), obtained
from the National Food Safety and Toxicology Center at Michigan State University, was
used for this study. Cultures were grown in Luria-Bertani broth (LB; Difco, Becton
Dickinson Microbiology Systems; Sparks, MD) containing 0 (control) or 1% sodium
benzoate (Fisher Scientific; Fair Lawn, NJ) at 37˚C for 24 h, and transferred a minimum
of three successive times at 24-h intervals before use. Cell counts were determined by
serial dilutions of the overnight culture and plating on LB agar.

RNA Extraction
The RNeasy® mini kit (Qiagen; Valencia, CA) procedure was used to extract total
RNA. Briefly, 1 ml of a 24-h culture was combined with 2 ml RNAprotect® bacteria
reagent (Qiagen; Valencia, CA) and incubated for 5 min prior to centrifugation at 10,000
x g (4˚C) for 10 min. The cell pellet was combined with lysozyme (3 mg/ml; Sigma
Aldrich; St. Louis, MO) in 100 µl 1x Tris-EDTA buffer (TE; Promega; Madison, WI) and
incubated for 5 min with frequent agitation. The remainder of the extraction steps were
followed according to the manufacturer’s instructions and yielded 30 µl total RNA in
DNase-RNase free water that was stored at -80˚C. RNA quantity (A260) and purity
(A260/A280; A260/A230) were determined using a Nanodrop ND-1000 spectrophotometer
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(Nanodrop Technologies; Wilmington, DE, USA). Extracted RNA from all samples was
diluted as appropriate to obtain equal concentrations for each treatment (35 ng/µl).

Nucleic Acid Amplification
Real-time one-step reverse-transcriptase PCR (rt-RT-PCR) was performed on
serially-diluted RNA extracts. SuperScript™ III Platinum® SYBR® green one-step rt-RT-PCR
kit reagents (Invitrogen; Carlsbad, CA) were utilized in 50 µl reactions (5 µl seriallydiluted RNA, 25 µl SYBR® green reaction mix, 2 µl BSA, and 1 µl SuperScript™ III reverse
transcriptase/Platinum® Taq Mix, 0.05 µg forward and reverse primers for the target
gene, and the remainder RNase-DNAse free water). Primer sequences (Table 2.1) were
developed for marA, eaeA, and hemX using Beacon Designer 4.0 software (Premier
Biosoft International; Palo Alto, CA), and previously reported primers were utilized for
stx1 (20). All tables and figures are found in an appendix located at the end of the
chapter. A Bio-Rad iCycler iQ™ multi-color real-time PCR detection system was used to
conduct rt-RT-PCR using the following parameters: 1) conversion of mRNA to cDNA, 35
min at 50˚C; 2) denature reverse-transcriptase, 2 min at 94˚C; 3) denature template, 45
sec at 94˚C; annealing of primers, 45 sec with appropriate temperature (Table 2.1); and
extension with Taq polymerase, 45 sec at 72˚C; repeated 50 times; 4) final extension, 7
min at 72˚C. All reactions were verified by gel electrophoresis, and all RT-PCR
experiments were conducted in triplicate for each RNA sample.
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Results and Discussion
Transcription of marA and stx1 was 1-log greater in E. coli O157:H7 grown in the
presence of 1% sodium benzoate as compared with the control, although cell numbers
for each were similar when plated on LB agar (7.28 and 7.57 log CFU/ml, respectively).
Table 2.2 lists the average cycle threshold (Ct) value and the limit of detection for each
target transcript under treatment and control conditions. As an example of rt-RT-PCR
results, output for marA is shown in Figure 2.1. Melt temperature analysis of rt-RT-PCR
revealed that a single, specific product was produced for each target gene transcript
(Figure 2.2). Gel electrophoresis confirmed rt-RT-PCR results revealing amplicons of the
appropriate size, where marA and stx1 products were visualized at a 1-log higher
dilution in cells grown in 1% sodium benzoate (Figure 2.3) than in control. Both control
and treated cells had similar transcription levels for eaeA. Under these conditions,
hemX was validated as an appropriate housekeeping gene as it was expressed at similar
levels in both treatments. It was equally important to design primers for the
housekeeping gene that could be utilized at multiple annealing temperatures. Each
primer set was optimized for the desired gene target as could be determined from the
melt temperature analysis showing single peaks (Figure 2.2).
Expression of marA can be induced by exposure to benzoate (33, 37), chlorine,
nitrite, acetic acid (33), pine oil (31), bile salts (34), spices and various food extracts (35),
low levels of tetracycline and chloramphenicol (17), salicylates (9, 37), and organic
solvents (2). Salicylic acid and deoxycholate have been shown to induce transcription of
46

the mar operon by binding to the repressor, MarR (27, 34). Once the repressor can no
longer bind to the operator region, transcription of marAB is induced. This mechanism
may play a role in the observed increase in transcription of marA when exposed to
sodium benzoate.
The stx1gene is encoded by a cryptic prophage, CP-933V, in E. coli O157:H7
strain EDL933 (32). Shiga-toxin production can be stimulated by the SOS response or
growth under limited iron conditions (23, 32, 42). The effect of macrolide and quinolone
antibiotics has been reported to increase Shiga-toxin production via phage induction
associated with a bacterial SOS response or phage-induced cell lysis (23, 43). However,
information on the response of stx1 to food antimicrobials is lacking. Leenanon et al.
(25) described an increase in production of stx-2 mRNA for E. coli O157:H7 following
acid adaptation or starvation. When the gene product of stx-2 was monitored with lacZ
fusions, there was no increase in -galactosidase activity (25). This could be due to an
increased sensitivity of RT-PCR assays when compared to -galactosidase activity, or an
indication that post-transcription control of toxin production may be involved (25).
Therefore, it is important to understand that our data are only indicative of increased
transcription of stx1, which may not lead to a subsequent increase in translation of Stx-1
or release of this toxin from the bacterial cell. Further work by Elhanafi et al. (2004) on
cold and cold-acid stress of E. coli O157:H7 showed no effect on translation of Stx2,
HylA, or EaeA production, but HylA and EaeA production were stimulated in an acidic
environment (12). Our data also do not show any increase in eaeA gene expression
between treated and untreated cells. This could indicate that once intimate attachment
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onto microvilli occurs, increase in eaeA expression is probably not critical for the
organism to grow and survive. However, it is likely that the level of expression of the
Shiga-toxins, and subsequent translation and toxin release, play critical roles in causing
pathogenic effects in the host, increasing the virulence and survival of the pathogen.

Conclusions
These data indicate that stx1 and marA genes could play a role in E. coli O157:H7
virulence and enhanced survival if cells are exposed to sodium benzoate, while eaeA
transcription was not altered. It is very important to understand the genetic response of
pathogens when exposed to antimicrobials in order to assess risk and minimize illness
from foodborne pathogens. While RT-PCR reactions can give insight to specific gene
expression responses, microarray technologies give researchers the ability to look at the
transcription response of all known genes for a microorganism. Our future goals include
transcriptome analysis of E. coli O57:H7 treated with sodium benzoate using
microarrays to obtain further insights into gene expression and gene regulation.
Understanding gene regulation by validating microarray results will aid in mapping out
metabolic pathways and mechanisms of bacterial survival and adaptations to stress. This
ultimately will lead to improvements in design and implementation of appropriate
control and mitigation strategies and minimizing foodborne disease outbreaks.
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Table 2.1. Primers for rt-RT-PCR assays to determine mRNA expression of stx1, marA,
and eaeA in E. coli O157:H7 when exposed to 0 and 1% sodium benzoate.
Annealing Product Product
Primer
Sequence (5’→3′)
temp (˚C)
Tm (˚C) size (bp)
stx1F
GTGGCATTAATACTGAATTGTCATCA
65
83.5
108
stx1R

GCGTAATCCCACGGACTCTTC

marAF

CGAGGACAACCTGGAATCAC

marAR

TGCGGCGGAACATCAAAG

eaeAF

GGCATGAGTCATACAATAAGAAAG

eaeAR

ATCGTCACCAGAGGAATCG

hemXF

GAAAATATTCGCTCTCGCCTGCTGG

hemXR

TGGCTTTGCAGGGTTTCCGG

1

59

86

261

61

84

223

-1

88

209

Primer set for the housekeeping gene, hemX, was utilized in all rt-RT-PCR reactions
using the optimal annealing temperature for each specific gene target.
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Table 2.2. Average cycle threshold (Ct) and limit of detection for marA, stx1, eaeA, and
hemX rt-RT-PCR product of mRNA from 0 and 1% sodium benzoate-treated E. coli
O157:H7.
0% sodium benzoate
1% sodium benzoate
1
Average
Limit of
Average
Limit of
Target gene
Ct value ± S.D.
detection
Ct value ± S.D.
detection
marA
34.1 ± 0.6
10-6
36.1 ± 0.75
10-7

1

stx1

40.0 ± 0.25

10-5

40.2 ± 0.7

10-6

eaeA

36.2 ± 0.6

10-6

35.5 ± 0.46

10-6

hemX

28.4 ± 0.33

10-3

27.3 ± 0.36

10-3

Minimum of three replicates; S.D. = one standard deviation.
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Figure 2.1. An example analysis of RT-PCR with marA mRNA showing the limit of
detection and Ct values for 0 and 1% sodium benzoate-treated E. coli O157:H7.
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Figure 2.2. Melt temperature analysis of rt-RT-PCR products for A) marA, B) stx1, C)
eaeA, and D) hemX.
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Figure 2.3. Agarose gel electrophoresis validation of A) marA and B) stx1 rt-RT-PCR
products (from three replicates) to verify a 10-fold increase in transcription of these
genes when treated with sodium benzoate. M 100 bp marker
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Chapter 3
Increased Transcription of the Phosphate Specific Transport
(Pst) System of Escherichia coli O157:H7 Exposed to 0.5% Sodium
Benzoate Determined with High-density Oligonucleotide
Microarrays and Reverse-transcriptase Polymerase Chain
Reaction
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Abstract
Sodium benzoate is a widely used food antimicrobial in drinks and fruit juices. A
microarray study was conducted to determine the transcriptional response of
Escherichia coli O157:H7 to 0.5% (w/v) sodium benzoate, and the phosphate specific
transport (Pst) system was found to be highly up-regulated. The Pst system is composed
of four subunits: PstS, a periplasmic phosphate binding protein; PstA and PstC, involved
in formation of the transmembrane portion of the Pst system; and PstB, an ATPase. This
system transports inorganic phosphate into bacterial cells under phosphate limited
conditions. Stationary phase E. coli O157:H7 grown in 150 ml Luria-Bertani broth (LB)
was exposed to 0 (control) and 0.5% sodium benzoate. Each treatment was duplicated,
sampled at 0 (immediately after exposure), 5, 15, 30, and 60 min. Total RNA was
extracted and analyzed with E. coli 2.0 Gene Chips. Significant ontology categories
affected by sodium benzoate exposure were determined with JProGO software.
Increased expression of the Pst system was observed after 5 min of exposure to
sodium benzoate; pstS, pstA, pstB, and pstC genes were up-regulated >2-fold (linear
scale) at 5, 15, 30, and 60 min. Increased expression of several other efflux systems,
such as AcrAB-TolC, was also observed.
The Pst system may act as an efflux pump under these stress-adapted conditions, as
well as increase transport of phosphorus to aid in DNA, RNA, ATP, and phospholipid
production. Understanding adaptations of E. coli O157:H7 under antimicrobial exposure
is essential to better understand and implement methods to inhibit or control its
survival in foods.
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Introduction
E. coli O157:H7 is a member of the enterohemorrhagic E. coli (EHEC) and causes
hemorrhagic colitis in humans. The symptoms of an E. coli O157:H7 infection generally
include severe abdominal cramps and diarrhea (often times bloody), which can lead to
death. In children under the age of five, infection can lead to a complication known as
hemolytic uremic syndrome (HUS), resulting in red blood cell destruction, renal failure,
and central nervous system complications (43). E. coli O157:H7 can cause disease at a
low infectious dose (10 - 100 cells) (39). This can be attributed to the tolerance of this
bacterium to low pH, which allows passage through the stomach and colonization in the
intestinal tract (39). E. coli O157:H7 has been linked as the causative agent in outbreaks
associated with unpasteurized apple and orange juice, and experimental data
demonstrate the tolerance of E. coli O157:H7 to acidic environments (5, 13, 40, 47).
While it is very hard to quantify the impact foodborne illnesses have in the United
States, it has been estimated that foodborne disease causes 76 million illnesses annually
and approximately 5,000 fatalities (36). There were 16,614 laboratory-confirmed cases
of foodborne illness from FoodNet participants in 2005 (about 15% of the United States
population), and E. coli O157:H7 was the causative agent in 2.8% of these cases (3). The
Centers for Disease Control and Prevention estimates that there are 73,000 cases of E.
coli O157:H7 illness annually, leading to an estimated 2,100 hospitalizations in the
United States (9). It was estimated that the cost of EHEC infections was $405 million
dollars in 2003 (22).
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The well-described virulence factors of E. coli O157:H7 include stx1, stx2, and
eaeA (27, 45). Shiga toxins are composed of two subunits. The B-subunit binds
glycolipids in the host, and the A-subunit inhibits protein synthesis via disruption of
ribosomal RNA (1). Shiga-toxins also cause hemorrhagic colitis, hemolytic uremic
syndrome (HUS), thrombocytopenia, hemolytic anemia, and renal failure (26). The gene
eaeA in enterohemorrhagic E. coli produces intimin, a 97-kDa protein that plays a role in
attachment onto and effacement of microvilli of the intestine (16, 21, 31, 35, 51).
Sodium benzoate is a food additive commonly used in acidic beverages due to its
relatively low pKa (4.2) and increased solubility (compared to benzoic acid). This
compound is generally recognized as safe and may be added at concentrations up to
0.1% in foods (21CFR184.1733). Benzoate is degraded in microorganisms via the ketoadipate pathway resulting in acyl CoA and succinic acid (12). These degradation
pathways serve as innate responses to weak acid resistance.
A general mechanism of inhibition for weak-acids starts with diffusion of the
undissociated compound through the cell membrane by passive diffusion. Once inside
the cell, the higher pH causes dissociation of the acid and lower intracellular pH i and
inhibition of membrane-bound transport (8). Eklund (17) determined that uptake
inhibition contributed to growth inhibition, but did not seem to completely explain this
phenomenon. Eklund (20) found that ΔpH (pH difference) was eliminated by sorbic acid
as well as methyl and butyl paraben, whereas the membrane potential (Δψ) was
maintained (19). This indicates more than simple inhibition of the proton motive force,
since the membrane potential maintained would allow for uptake of essential
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compounds for cellular maintenance. It has been determined that dissociated weak
acids also contribute a small portion to growth inhibition, which cannot be explained by
the effects of pHi(18). Sorbic acid, sorbic alcohol and sorbic aldehyde have been found
to cause similar levels of inhibition, demonstrating a mechanism of inhibition other than
a weak acid effect (49). Bracey and others (7) found that pHi was not altered in
Saccharomyces cerevisiae exposed to sorbic acid. However, a higher ADP/ATP ratio was
found indicating that the cell was expending energy to maintain pHi (7), and this
expenditure of ATP was theorized to decrease cellular growth.
Membrane disruption has also been attributed as a mechanism of inactivation by
sorbic acid (7, 49). Krebs and et al. (29) observed a reduction in phosphofructokinase
activity in Saccharomyces cerevisiae exposed to sorbic acid (29). The disruption of
glycolysis was thought to be caused by a decrease in pHi that decreased the enzymatic
activity of phosphofructokinase. Nitrogen starvation and benzoic acid treatment inhibit
growth of Saccharomyces cerevisiae. However, when used in combination, they are
cytocidal (23). It was found that benzoic acid inhibited the break-down of cytosolic
compounds to form amino acids and nucleotides necessary for growth and survival (23).

Phosphate Specific Transport (Pst) of Escherichia coli
The acquisition of phosphorus is essential for bacteria to supply energy and
synthesize DNA, RNA, lipopolysaccharides, and phospholipids. Microorganisms must
transport inorganic phosphorus (Pi) into the cytoplasm to survive. The first step in this
process for E. coli is to transport organic and inorganic forms of phosphorus across the
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cell wall. In E. coli, there are two common pore-forming proteins, OmpC and OmpF.
However, under phosphate limited situations, a third anion binding porin, PhoE, is
expressed in order to sequester phosphorus in the periplasm (41).
The Pst system is in the ATP binding cassette (ABC) superfamily of transporters
and is one mechanism of transporting Pi across the cell membrane. This system is
known to be expressed when Pi concentration is below 0.001 M (50). The Pst system
has a high affinity for binding of phosphate and is composed of four proteins, PstS, PstC,
PstA, PstB, and PhoU (50). The mechanism by which phosphate is transported across
the cell membrane is shown in Figure 3.1. All tables and figures are found in an
appendix located at the end of the chapter. The gene pstS (formerly phoS) encodes a
phosphate binding protein that binds Pi in the periplasmic space where it can be
transported across the cell membrane (37, 38, 52). PstC and PstA are transmembrane
proteins that form a passage across the cell membrane (14), while PstB catalyzes the
movement of phosphorus into the cytoplasm by hydrolysis of ATP (11).
PhoR and PhoB regulate the Pho regulon, of which the Pst system is a member.
PhoR is a transmembrane signal transduction protein that senses low levels of P i in the
periplasm. PhoR has an extracellular sensory domain and an intracellular signaling
domain (48). The mechanism by which phosphate concentration is sensed by PhoR is
shown in figure 3.2. Under phosphate limited conditions, PhoR undergoes
autophosphorylation and acts as a histidine kinase that phosphorylates PhoB (Figure
3.2) (33, 34). Once PhoB is activated, it stimulates the Pho regulon by binding to the
‘Pho box’ consensus sequence stimulating transcription of pstS (32, 33). In addition to
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pstSCAB-phoU, PhoB also regulates the expression of PhoA, which is a periplasmic
alkaline phosphatase that frees Pi from phosphate containing compounds so it is
available for uptake into the cytoplasm. PhoU is a 21 kDa cytoplasmic protein that is
necessary for repression of the Pho regulon (2, 34). PhoU acts with phosphate-bound
PstS, PstA, PstB, and PstC to form a repressor complex keeping PhoR in the
dephosphorlyated state (Figure 3.3). PhoU also acts to promote dephosphorylation of
PhoB, thus inactivating this protein (48).
A role other than phosphate transport has been determined for the Pst system in
Mycobacterium smegmatis. A ciprofloxacin-resistant strain of M. smegmatis strain was
found to over-express the Pst operon when grown in sufficient quantities of phosphorus
(4, 6, 10). The pstB gene was also shown to have increased amplification on the
chromosome of the ciprofloxacin-resistant strain of M. smegmatis (10). When the pstB
gene was mutated, the minimum inhibitory concentration of ciprofloxacin for M.
smegmatis was greatly reduced (4). It was also demonstrated that the ciprofloxacin
resistant strain had a much greater efflux of this fluoroquinolone from the cell
compared to that of the wild type or pstB mutant (4). The fluoroquinolone resistant M.
smegmatis strain showed increased phosphate uptake that was diminished along with
ciprofloxacin resistance when pstB was mutated (6). These results indicate that the Pst
system serves as an efflux mechanism of ciprofloxacin for M. smegmatis in addition to
the traditional role as a high-affinity transporter of phosphorus.
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Materials and Methods
Escherichia coli O157:H7
Escherichia coli O157:H7 strain EDL 933, obtained from the National Food Safety
and Toxicology Center at Michigan State University, was used for this study. Cultures
were grown in 125 ml Luria-Bertani broth (LB; Difco, Becton Dickinson Microbiology
Systems; Franklin Lakes, NJ) at 37˚C for 24 h, and transferred a minimum of three
successive times at 24-h intervals before use. The entire volume of stationary-phase
cells were centrifuged at 8000 x g for 10 min at 4˚C. The cell pellet was resuspended in
LB containing 0 (control) or 0.5% (w/v) sodium benzoate (Fisher Scientific; Fair Lawn,
NJ). At every sampling time, cell counts were determined by surface plating on Sorbitol
MacConkey Agar (SMAC; Difco, Becton Dickinson Microbiology Systems; Franklin Lakes,
NJ.

Experimental Design
A completely randomized design with repeated measures was used to study the
effects of sodium benzoate exposure on E. coli O157:H7. The control (0%) and
treatment (0.5%) sodium benzoate conditions were replicated once and sampled over
five time points [0 (immediately after exposure), 5, 15, 30, and 60 min].

Total RNA Isolation
The RNeasy Mini Purification Kit (Qiagen; Valencia, CA) was used to extract total
RNA from E. coli O157:H7 cultures. 1.2 ml RNAlater Stabilization Reagent (Qiagen;
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Valencia, CA) was combined with 0.6 ml E. coli O157:H7. RNAlater immediately
stabilizes RNA to help safeguard against degradation of mRNA. After 10 min at room
temperature, the mixture was centrifuged at 8000 x g for 10 min under refrigeration
(Eppendorf 5417C; New York, NY). The supernatant was decanted and the bacterial
pellet was stored at -70˚C until further processed (approx. 2-10 hr).
100 µl tris-EDTA buffer (10 mM Tris-Cl, 1 mM EDTA, ph 8.0; Promega; Madison,
WI) containing lysozyme (3 mg/ml; Sigma-Aldrich; St. Louis, MO) was added to each cell
pellet. The pellet was thoroughly mixed and incubated at room temperature for 10 min.
This allowed for disruption of the cell wall and membrane to allow for extraction of
RNA. 350 µl buffer RLT was combined with the tris-EDTA/lysozyme cell suspension to
further lyse the cells. Buffer RLT contains guanidine thiocyanate which aids in
denaturing proteins, effectively inactivating ribonucleases to preserve RNA quality. The
total volume was combined with 250 µl of 200 proof ethanol (Aaper Alcohol; Shelbyville,
KY) to solubilize the cell lysate, and the entire sample was transferred to the RNeasy
Mini spin column in a collection tube and centrifuged at 8000 x g for 15 sec at room
temperature (Sorvall Biofuge Pico; Kendro, Germany). The silica-based membrane
efficiently binds up to 100 µg of RNA longer than 200 bases. The collection tube and
eluate were discarded, and the spin column was placed in a new collection tube. 700 µl
buffer RW1 was applied to the column, centrifuged, and flow-through was discarded as
described previously. RW1 also contains guanidine thiocyanate to help disrupt protein
structure and ethanol to solubilize and remove other cellular material. Twice, 500 µl of
buffer RPE was applied to the spin column allowing 5 min prior to centrifugation at 8000
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x g for 15 sec. Ethanol also is a constituent of RPE and serves a primary role of removing
residual salts from previous buffers. The spin column was placed in a 1.5 ml collection
tube that was used for long-term storage. In order to elute RNA from the spin column,
30 µl RNase-free water was applied directly to the membrane and centrifuged at 8000 x
g for 15 sec. Ten RNA samples were extracted for each treatment and replicate (40/
time point). The ten samples were pooled and re-aliquoted to remove variation in RNA
concentration from differing RNA extraction efficiencies. The RNA eluate was stored at 80˚C until evaluated for quantity, quality, and purity.

Evaluation of RNA Quality, Quantity, and Purity
The NanoDrop spectrophotometer (NanoDrop Technologies; Wilimington, DE)
was utilized to determine absorbance of samples at 230, 260, and 280 nm. RNA
concentration is determined by absorbance at 260 nm (1 absorbance unit=40 µg/ml).
The A260 / A230 and A260 / A280 ratios indicate contamination (e.g. proteins, ethanol, salts)
and should fall between 1.8 to 2.1. Lower ratios may interfere with down-stream
processing of RNA for microarrays and RT-PCR.
In addition to spectrophotometric analysis, RNA samples were also analyzed for
quality using the Agilent 2100 electrophoresis bioanalyzer (Agilent Technologies; Santa
Clara, CA). This analysis allows for visualization of 23S and 16S rRNA bands, assuring
that there is no degradation of RNA and the absence of chromosomal DNA.
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High Density Oligonucleotide Microarray Analysis
cDNA Synthesis
The Affymetrix protocol for GeneChip prokaryotic processing was followed for
this study. In vitro synthesized polyadenylated transcripts for Bacillus subtilis
(Affymetrix; Santa Clara, CA) were diluted 1 x 10-2.5 and spiked-into the primer annealing
master mix at a volume of 2 µl. This “spike-in” is evaluated in the final processing of the
microarray as a means of monitoring the assay sensitivity and performance from the
beginning to final stages. Ten micrograms of total RNA was added to the primer
annealing master mix (final concentration 0.33µg/µl). Ten microliters of random
primers (Invitrogen; Carlsbad, CA) at a concentration of 75 ng/µl (final concentration 25
ng/µl) and nuclease-free water (Ambion; Austin, TX) were added to bring the entire
master mix volume to 30 µl. The following conditions were utilized to anneal random
primers: 70˚C for 10 min; 25˚C for 10 min; chill to 4˚C (PCR Sprint Thermal Cycler;
Thermo Fisher Scientific; Waltham, MA).
The RNA/primer master mix was centrifuged at 5000 x g for 1 min at room
temperature. The SuperScript first-strand synthesis system (Invitrogen; Carlsbad, CA)
reagents and SUPERase-In (Applied Biosystems; Foster City, CA) were combined with the
30 µl RNA/primer master mix as described in Table 3.1. The cDNA synthesis conditions
were: 25˚C for 10 min; 37˚C for 60 min; 42˚C for 60 min; 70˚C for 10 min; chill to 4˚C.
Remaining RNA was degraded with the addition of 20 µl/rxn of 1N NaOH and incubated
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at 65˚C for 30 min. The reaction was neutralized with the addition of 20 µl/rxn of 1N
HCl.

Purification and Quantitation of cDNA
The MinElute PCR Purification Kit (Qiagen; Valencia, CA) was utilized to clean up
the cDNA synthesis product prior to further microarray processing. Five volumes of
buffer PB were added to the cDNA product, placed on a MinElute spin column, and
centrifuged at room temperature at 5000 x g for 1 min. Eluate was discarded and 750 µl
of buffer PE was applied to the column and centrifuged as described above. Residual
ethanol from the PE buffer was allowed to evaporate from the spin column prior to
eluting cDNA with 12 µl buffer EB. The resulting purified product was analyzed as
previously described with the NanoDrop spectrophotometer to determine cDNA yield.

cDNA Fragmentation
Purified cDNA (3 µg) was combined with 10X One-Phor-All buffer (GE Healthcare;
Buckinghamshire, England), DNAse I (0.6 U/µl; GE Healthcare; Buckinghamshire,
England), and nuclease-free water as described in Table 3.2. The reaction was held at
37˚C for 10 min followed by 98˚C for 10 min to inactivate DNAse I.

Terminal Labeling
The GeneChip DNA Labeling Reagent (Affymetrix; Santa Clara , CA) was used to
label the 3’ termini of the fragmented cDNA products with biotin. Volumes of reagents
utilized in this reaction are listed in Table 3.3. The reaction was held at 37˚C for 60 min
followed by addition of 2 µl of 0.5M EDTA (Invitrogen; Carlsbad, CA) to arrest the
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labeling reaction by inactivating the terminal deoxynucleotidyl transferase (Promega;
Madison, WI).

cDNA Target Hybiridization
The biotin labeled, fragmented cDNA was added to the hybridization master mix.
Table 3.4 describes the reagents utilized in this reaction. The B2 control oligo acts as a
hybridization control and allows for alignment of the GeneChip microarray in the
analysis software. Herring sperm DNA was used as a blocking agent during hybridization
to prevent improper annealing of cDNA fragments with probes.
The E. coli Genome 2.0 Array (Affymetrix; Santa Clara, CA) was allowed to
equilibrate to room temperature. This GeneChip allows detection of transcripts from E.
coli K12 (MG1655) as well as a uropathogenic strain (CFT073) and two
enterohemorrhagic strains of the serotype O157:H7 (EDL933 and Sakai). 200 µl of the
hybridization solution was added to the GeneChip and the array was placed in the
hybridization oven (Affymetrix; Santa Clara, CA) at 45˚C, 60 RPM for 16 hr. The
hybridization solution was then removed and replaced with 80 µl of non-stringent wash
buffer (wash buffer A; 6x SSPE, 0.01% Tween-20) and the GeneChips were stored at 4˚C
until washed and stained.

GeneChip Washing, Staining, and Scanning
The GeneChip Operating Software (GCOS; Affymetrix; Santa Clara, CA) controlled
the operation of the Fluidics Station 450 (Affymetrix; Santa Clara, CA). Streptavidin
phycoerythrin (SAPE; Table 3.5) was loaded into the first and third 1.5 ml staining vial in
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the fluidics station, while the second stain vial contained an antibody solution mix (Table
3.6). The Mini_prok2v1_450 fluidics station protocol (Table 3.7) was followed for
washing and staining hybridized biotin labeled cDNA fragments. The GeneChip Scanner
3000 (Affymetrix; Santa Clara, CA) and GCOS were used to produce .cel files which
contained the fluorescence intensity data for a probe. Each target sequence contains 11
25-oligomer probes that are spread throughout the entire sequence (perfect match) as
well as 11 25-oligomer probes that match the target with the exception of the 13 th
nucleotide which is a mismatch to the desired target sequence and indicates nonspecific binding (mismatch). Fluorescence data for these 22 probes are combined into a
probe set for further analysis.

Statistical Analysis of Microarray Data
The R programming environment (v 2.5.1) was used for all microarray data
analysis. First, GCOS generated CEL files, CDF file, and probe file were uploaded into the
GCRMA package (v 2.0.0) (54). This program normalizes microarray data by using
Affymetrix probe sequence affinities based on the specific probe sequence in addition to
normalization from background noise also used in robust multiarray average (RMA)
analysis. Following normalization with the GCRMA package, the intensities for probe
sets were compared among treated and control cells across all time points using the
microarray analysis of variance package (MAANOVA; v 1.4.1) (53). Next, the positive
false discovery rate (pFDR; q-value) was determined to differentiate genes which were
significantly regulated in response to exposure of sodium benzoate (qvalue; v 1.10.0)
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(15). A subset of genes which were differentially regulated (q < 0.05) were determined
and used for further analysis.

Selection of genes for validation with real-time one-step reversetranscriptase PCR (rt-RT-PCR)
Three tools were used to analyze microarray results so a subset of significantly
regulated genes could be selected for further validation with rt-RT-PCR. The Pathway
Tools Omics Viewer (SRI International; Menlo Park, CA) was used to visualize metabolic,
transport, and signaling pathways in addition to proteins integral to the membrane and
periplasm specific to E. coli O157:H7 (42). The output would link through pathway tools
to EcO157Cyc (SRI International; Menlo Park, CA) and give further insight to pathways,
molecular interactions, proteins, and genes. However, the database specific to E. coli
O157:H7 was computationally generated with very little curation based on findings in
current literature. When the pathways of interest were homologous to E. coli K-12, the
EcoCyc database which receives extensive literature based curation was utilized to gain
further insight to functional and regulatory information for a pathway of interest (28).
A tool was also used to analyze the gene products that were significantly
regulated with respect to their biological processes, cellular components, and molecular
functions. These ontology terms were analyzed with the Java Tool for the Functional
Analysis of Prokaryotic Microarray Data using the Gene Ontology (JProGO;
Braunschweig, Germany) (46). Wilcoxon’s nonparametric test was used to determine
statistically significant ontology nodes using an FDR multiple hypothesis correction
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(p<0.05). These outputs allowed for selection of genes which would undergo further
validation of expression using rt-RT-PCR.

Selection of housekeeping genes for standardization of rt-RT-PCR
Secondary validation of microarray data was achieved with the Pfaffl method
which incorporates the efficiency of a PCR reaction in addition to the difference in Ct
values between the treated and control samples (44). The equation below shows how
the ratio is calculated to determine increased or decreased levels of target mRNA when
comparing the control and treated sample. This difference is also standardized with one
or more reference or housekeeping genes which are expressed at the same level
between the control and treatment.

From the microarray data, genes were selected which had a highly nonsignificant q-value (q>0.98). Genes were excluded if their function was not known, or if
there was a high amount of variability between replicate microarrays. rt-RT-PCR was
used to validate these genes as appropriate housekeeping markers for microarray
validation. Each sample was run in triplicate and there were a total of six cycle
threshold values for each treatment within each time point. A completely randomized
design with repeated measures was used to assure there was no difference in cycle
threshold values within each time point (p > 0.05; SAS v9.1; Cary, NC). This
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methodology helped to assure that there was no difference in mRNA expression
between treatments.

Nucleic Acid Amplification
rt-RT-PCR was performed on RNA extracts as a means of microarray validation.
SuperScript™ III Platinum® SYBR® green one-step rt-RT-PCR kit reagents (Invitrogen;
Carlsbad, CA) were utilized in 25 µl reactions (2.5 µl serially-diluted RNA, 12.5 µl SYBR®
green reaction mix, 1 µl BSA, and 0.5 µl SuperScript™ III reverse transcriptase/Platinum®
Taq Mix, 0.025 µg forward and reverse primers for the target gene, and the remainder
RNase-DNAse free water). Primer sequences (Table 3.8) were developed using Beacon
Designer 4.0 software (Premier Biosoft International; Palo Alto, CA). The Bio-Rad My
iQ™ single color real-time PCR detection system (Hercules, CA) was used to conduct rtRT-PCR using the following parameters: 1) conversion of mRNA to cDNA, 35 min at 50˚C;
2) denature reverse-transcriptase, 2 min at 94˚C; 3) denature template, 30 sec at 94˚C;
annealing of primers, 45 sec at 55˚C; and extension with Taq polymerase, 30 sec at 72˚C;
repeated 40 times; 4) final extension, 5 min at 72˚C; 5) melt curve . All rt-RT-PCR
experiments were conducted in triplicate for each RNA sample and a negative control
was included for each assay.

Results and Discussion
Microarray analysis revealed a large number of genes that were significantly
regulated in response to 0.5% sodium benzoate. As shown in Table 3.9, the number of
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genes which were differentially regulated increased with exposure time, and after 60
minutes of exposure to sodium benzoate 1707 genes were found to be differentially
expressed (q≤0.05).
Ontology analysis allowed for insight to genes which responded to sodium
benzoate exposure based on biological process, molecular functions, or cellular
components. Genes categorized into biological processes were the greatest to respond
across all time points (Table 3.10). There were a large number of genes associated with
biological process nodes which responded quickly to sodium benzoate exposure (0 and
5 min). Most of these nodes were associated with metabolic activities such as protein
biosynthesis. Genes associated with the ribosome and RNA binding were also found for
these early time point. Genes involved in protein translation respond very early to the
stimulus of sodium benzoate.
There was a rapid decline in significant ontology categories at 15 min, but an
increase was observed for 30 and 60 min. At 15 min the biological process nodes
represented genes that responded to unfolded proteins and alcohol metabolism.
Significant cellular component nodes were found for genes involved with the cell
membrane. Genes were also found to be regulated that responded to the molecular
functions of carbohydrate transport and nickel ion binding.
Genes associated with molecular functions and cellular components had a
greater response to sodium benzoate after 30 and 60 min of exposure. Molecular
function nodes which had increased expression at these time points pertained to RNA
and ATP binding activity as well as carbohydrate transport. The significant cellular
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component nodes at these times were oriented around the ribosome and products
which were integral to the membrane or part of the inner membrane. Biological
process nodes associated with a response to chemical and antibiotic stimuli were found
after 15 min of exposure and continued until 60 min. Many of these genes are
components of efflux pumps as well as transcription regulators, such as marA, the
multiple antibiotic resistance regulon activator.
Phosphate transport was one biological process node which was significantly
regulated at 30 and 60 min. This insight spurred a closer look at this finding. Increased
expression after only 5 min was found for all genes associated with the high affinity
phosphate transport system (pstSCAB-phoU) when E.coli was exposed to sodium
benzoate. Therefore, validation of the genes integral to the pst system as well as the
transcriptional regulators (phoRB) for this operon was conducted using the Pfaffl
method.
The glutamine synthetase adenyltransferase (glnE) gene catalyzes the addition of
AMP to a subunit of glutamine synthetase. PspF is a σ54 dependent transcriptional
activator that is cis-acting on the phage-shock protein (psp) operon and has been found
to be constitutively expressed (24, 25). No significant differences were found in Ct
values for these genes across treatments within time points (p > 0.05). Therefore, glnE
and pspF were utilized as the housekeeping genes by which rt-RT-PCR assays were
normalized in the Pfaffl method.
The log2 fold-change between 0.5% sodium benzoate treated E. coli O157:H7
cells and that of the control conditions is shown in Table 3.11. Microarray generated
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values for the pstSCAB and phoBR genes in the Pho regulon indicate at least a 2.8-fold
induction (linear-scale) when E. coli O157:H7 was exposed to sodium benzoate. When
these values were validated with rt-RT-PCR, phoB and phoR transcription levels were not
as high as indicated by microarray analysis. The microarray results indicated an 11- to
17-fold increase in transcription of phoB, and at least a 34-fold induction of phoR when
assessed on a linear scale. However, when determining transcript levels with rt-RT-PCR,
the highest induction observed was a 5.2-fold increase for phoB at 5 min. This indicates
that for these two transcripts, there was increased probe fluorescence seen in the
microarray analysis. This could be attributed to non-specific binding of cDNA to probe
sets in the microarray assay, which would arbitrarily increase the observed fluorescence.
Also, typically the Affymetrix prokaryotic microarrays are only exposed once with
phycoerythrin, but in this study all arrays were exposed twice to this fluorophore. This
could also increase the level of fluorescence, but since all arrays were processed in the
same manner this result should have been negated when determining the ratio of the
control to treated conditions. Also, when comparing the induction levels for pstSCAB
observed in microarray and rt-RT-PCR, very similar results were obtained (Table 3.11).
This support non-specific binding to the phoBR probes in the Affymetrix E. coli 2.0
microarrays, thereby artificially inflating the fluorescence values obtained. This stresses
the importance of validating microarray results with a secondary method such as rt-RTPCR or Northern hybridization. Nevertheless, increased transcription was observed for
pstSCAB and phoBR when E. coli O157:H7 was exposed to 0.5% sodium benzoate (Table
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3.11). The Ct values and standard deviations obtained from the validation of
transcription levels with rt-RT-PCR are listed in Table 3.12.
PhoU was shown to have increased transcription across all time points (Table 3.
13). However, these values were not validated with rt-RT-PCR, and like phoBR, may
have arbitrarily high fold-changes detected with microarrays. The polyanion porin,
PhoE, was not found to be differentially regulated at any time point in the microarray
study. This suggests that transcription of this gene is not stimulated under these growth
conditions. If phosphate was limited, transcription of this gene should have increased to
help sequester phosphate and other organic molecules that bound phosphorus from the
growth medium.
The pstSCAB-phoU and phoBR genes may have increased transcription to serve
as an efflux pump in addition to phosphate transport. Although this phenomenon has
not been documented in E. coli, it has recently been determined for Mycobacterium
smegmatis (4, 6). Several components of other multidrug efflux pumps were also
shown to have increased transcription in response to exposure with 0.5% sodium
benzoate (Table 3.14). Although there are several different systems for transporting
these compounds from the cytoplasm, only one porin (TolC) is used to span the outer
membrane. In this study, tolC transcription was not observed to be increased while the
proteins that span the cell membrane and periplasm, such as those cited in Table 3.12,
were shown to have increased expression.
These results indicate that there is an increased need for phosphate when E. coli
O157:H7 is exposed to sodium benzoate. Therefore, if phosphate could be limited, E.
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coli O157:H7 could have decreased ability to adapt and survive this stressful
environment. If phosphate is depleted, the microorganism’s ability to repair DNA and
synthesize mRNA would be hampered. Protein biosynthesis would also be negatively
influenced that would in turn reduce enzymatic activity. The cell would also have
lowered ability to produce lipopolysaccharides and phospholipids in the cell membrane.
Most importantly, the energy supply of the cell would be greatly impacted under
restriction of intracellular phosphate.
The pst system has been found to be a virulence factor in E. coli O78, causes
airsacculitis and septicemia in poultry. When the pst system was mutated, the
infectivity of this strain was attenuated in an avian model and fewer isolates were
obtained from infected tissues (30). The mutated strain was also less able to survive
acid-shock treatment (pH 3.0) when compared to the wild-type and had a two-fold
lower MIC for polymixin (30). Although these results were found in an extraintestinal E.
coli, they indicate that the pst system plays a large role in the ability of E. coli O78 to
survive and cause illness. This observation has also been made in Proteus mirabilis,
which causes complicated urinary tract infections. When the pstS and pstA genes were
inactivated with Tn5 insertions, the Pho regulon was constitutively expressed. Although
the mutant cells grew and survived in urine and growth media in vitro, they did not
cause urinary tract infections in a murine model. When these mutants were
complemented with functional pstS and pstA, the ability to cause urinary tract infections
was restored to that of the wild-type. Both of these examples demonstrate the
importance of the pst system in survival and pathogenicity of microorganisms.
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Conclusions
The pst system is up-regulated in response to sodium benzoate in E. coli
O157:H7. This system would give E. coli O157:H7 the ability to recharge intracellular
phosphate supplies to rapidly produce several compounds such as ATP, nucleic acids,
and phospholipids in response to this adverse environment. This system has been
shown to play a role in virulence and pathogenicity in other microorganisms and is part
of the adaption of E. coli O157:H7 to weak acids. In addition to the known role as a
high-affinity transport system for phosphate, the pst system may also serve as an efflux
pump allowing removal of benzoate.
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Table 3.1. cDNA synthesis master mix components.
Reagent

Volume per reaction (µl)

5X First-strand cDNA Buffer

12

100 mM DDT

6

10 mM dNTP Mix

3

SUPERase-In (20 U/µl)

1.5

Superscript II (200 U/µl)

7.5

RNA/primer Hybridization

30
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Table 3.2. cDNA fragmentation master mix components.
Reagent

Volume per reaction (µl)

10x One-Phor-All Buffer

2

cDNA

15

DNAse I

1.8

Nuclease Free Water

1.2
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Table 3.3. Terminal labeling of cDNA fragments with biotin master mix components.
Reagent

Volume per reaction (µl)

5x Reaction Buffer

10

GeneChip DNA Labeling Reagent, 7.5mM

2

Terminal Deoxynucleotidyl Transferase

2

Nuclease Free Water

16

Fragmented cDNA Product

20
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Table 3.4. Biotin labeled cDNA hybridization master mix components.
Reagent

1

Volume per reaction (µl)

2x Hybirdization Buffer1

40

3 nM B2 Control Oligo

1.3

10 mg/ml Herring Sperm DNA

0.8

50 mg/ml BSA

0.8

100% DMSO

6.2

Nuclease Free Water

5.9

Fragmented and Labeled cDNA Product

25

200 mMMES, 2M [Na+], 20 mM EDTA, 0.01% Tween-20
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Table 3.5. Streptavidin phycoerythrin (SAPE) staining solution components.
Volume per
Reagent
Final concentration
reaction (µl)
2x MES stain buffer
600
1x
50 mg/ml BSA

48

2 mg/ml

1 mg/ml streptavidin
phycoerythrin
Nuclease free water

12

10 µg/ml

540
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Table 3.6. Antibody solution mix components.
Volume per
reaction (µl)
300

Reagent
2x MES Stain Buffer

Final
concentration
1x

50 mg/ml BSA

24

2 mg/ml

10 mg/ml Goat IgG

6

0.1 mg/ml

0.5 mg/ml Anti-streptavidin Antibody
(goat), Biotinylated

6

5 µg/ml

Nuclease Free Water

540
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Table 3.7. Mini_prok2v1_450 fluidics station program.
Step

Temperature (˚C)

Post Hyb Wash
#1
Post Hyb Wash
#2
1st Stain

30

2nd Stain

35

3rd Stain

35

Final Wash

35

50
35

Description
10 cycles of 2 mixes/cycle with Wash
Buffer A
4 cycles of 15 mixes/cycle with Wash
Buffer B
Stain the probe array for 5 min in SAPE
Stain the probe array for 5 min in
Antibody Solution Mix
Stain the probe array for 5 min in SAPE
5 cycles of 4 mixes/cycle with Wash
Buffer A
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Table 3.8. Primers for rt-RT-PCR assays to determine mRNA expression of pstS, pstC,
pstA, pstB, phoB, phoR, glnE, and pspF in E. coli O157:H7 when exposed to 0 and 0.5%
sodium benzoate.
Product
Product
Primer
Sequence (5’→3′)
Tm
size
(˚C)
(bp)
TGACACTTACCAGAAAGAAACC
86
233
pstSF
pstSR
TACCATCCAGCACCAGTTC
pstCF

GCCTTTGGTATCGGTATCC

pstCR

TTGGTGAACGGAAGAACG

pstAF

GGATTTATCTGGCGGAATATGG

pstAR

TACGGCACCAGTTTCAGC

pstBF

CTTCTACTACGGCAAATTCC

pstBR

GGTTTCGTTCCACAATGC

phoBF

CGAAGCGGAAGATTATGACAG

phoBR

TCAACATCACCACTGGAATATC

phoRF

TCTGGTGTAACGGTCTGG

phoRR

CAACTGTTTGTGGGTATAAGG

glnEF

GGATGGCTTCGTCTATCG

glnER

GAGCTGGAACACCTGAAC

pspFF

TCTGCTGGATTCCGAACTG

pspFR

GCATACCAACCGCACATTC

96

85

179

86.5

229

87

379

83.5

158

85.5

200

88

361

86.5

226

Table 3.9. Number of differentially regulated genes over time (q<0.05) when E. coli
O157:H7 is exposed to 0.5% sodium benzoate
Time
Number of genes
(min)
differentially regulated
270
0
5

458

15

564

30

795

60

1707
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Table 3.10. Number of significant ontology nodes within biological process, cellular
components, and molecular function as determined with JProGO.
Biological
Cellular
Molecular
Time
p-value
Process
Components
Function
51
8
11
5.1077E-4
0
5

57

0

3

5.1851E-4

15

4

2

6

1.0249E-4

30

14

10

13

2.7975E-4

60

32

15

26

6.3335E-4
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Table 3.11. Increased transcription of pstS, pstC, pstA, pstB, phoB, and phoR mRNA in E.
coli O157:H7 when exposed to 0.5% sodium benzoate and analyzed with high density
oligonucleotide microarrays and validated with rt-RT-PCR.
Target
Microarray log2
Microarray
rt-RT-PCR log2
mRNA
Time
fold-change
q-value
fold-change
1
pstS
0
-0.02
0.14
Nd2

pstC

pstA

pstB

5

2.4

9.65 E-6

2.8

15

2.7

4.41 E-6

2.7

30

2.6

5.14 E-6

2.5

60

2.5

6.83 E-6

3.3

0

-0.7

0.01

nd

5

2.8

6.9 E-6

1.8

15

2.9

9.49 E-6

1.7

30

2.8

7.42 E-6

1.8

60

3.4

5.17 E-6

1.9

0

-1.14

0.02

nd

5

2.3

2.29 E-5

2.9

15

2.5

1.47 E-5

3.1

30

2.5

1.62 E-5

3.3

60

2.4

1.86 E-5

3.1

0

-1.3

0.04

nd

5

1.5

0.0003

2.1

15

2.0

7.33 E-5

2.0

30

1.9

9.25 E-5

2.2
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Table 3.11. Continued
Target
mRNA
Time
pstB
60
phoB

phoR

1

2

Microarray log2
fold-change
2.0

Microarray
q-value
7.01 E-5

rt-RT-PCR log2
fold-change
2.5

0

1.9

0.01

nd

5

3.8

2.29 E-5

2.4

15

3.5

1.8 E-5

2.1

30

4.1

1.4 E-5

1.7

60

3.8

2.19 E-5

2.2

0

2.3

0.001

nd

5

5.1

1.53 E-5

2.0

15

5.7

8.46 E-6

2.0

30

6.0

5.11 E-6

1.6

60

5.3

1.32 E-5

1.9

q-value for differentially regulated genes ≤0.05.
Not determined
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Table 3.12. Average cycle threshold (Ct) values (n=6) of rt-RT-PCR for pstS, pstC, pstA,
pstB, phoB, and phoR mRNA in E. coli O157:H7 when exposed to 0 and 0.5% sodium
benzoate.
0% Sodium Benzoate
0.5% Sodium Benzoate
Target
Std.
Std.
mRNA
Time
Ct
Deviation
Ct
Deviation
pstS
5
13.93
0.42
10.78
0.91

pstC

pstA

pstB

phoB

15

13.88

0.22

10.47

0.38

30

15.28

0.47

10.72

0.48

60

14.41

0.38

10.91

0.17

5

15.99

0.3

14.01

0.15

15

15.49

0.3

13.25

0.14

30

15.25

0.48

12.97

0.43

60

15.19

0.3

13.2

0.38

5

12.96

0.24

10.40

0.31

15

13.15

0.33

10.25

0.18

30

13.33

0.46

10.23

0.18

60

13.5

0.32

10.91

0.36

5

13.27

0.25

10.76

0.53

15

13.08

0.41

10.33

0.14

30

12.84

0.5

9.84

0.17

60

13.29

0.29

10.46

0.4

5

14.42

0.65

11.72

0.49

15

14.5

0.32

11.8

0.28
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Table 3.12. Continued
Target
mRNA
phoB

phoR

Time
30

0% Sodium Benzoate
Std.
Ct
Deviation
14.85
0.54

0.5% Sodium Benzoate
Std.
Ct
Deviation
11.19
0.17

60

14.54

0.27

12.02

0.27

5

14.27

0.49

11.65

1.79

15

14.24

0.27

11.24

0.1

30

15.18

0.58

11.14

0.23

60

13.87

0.17

11.6

0.38
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Table 3.13. Transcription of phoU mRNA in E. coli O157:H7 when exposed to 0.5%
sodium benzoate and analyzed with high density oligonucleotide microarrays.
Target
Time
Microarray log2
Microarray
mRNA
(min)
fold-change
q-value
phoU
0
-1.7
0.019
5

1.3

0.0043

15

2.1

0.00041

30

1.7

0.0013

60

1.6

0.0015
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Table 3.14. Log2 fold changes obtained with microarray studies to determine
transcription of genes involved in multidrug efflux in E. coli O157:H7 when exposed to
0.5% sodium benzoate.
Time (min)
Target
Efflux
0
5
15
30
60
mRNA
pump
acrA
AcrAB-TolC
0.11
0.2
0.6
1.4
1.8

acrB

tolC

acrD

emrA

emrB

1
2

AcrAD-TolC

EmrAB-TolC

(0.592)

(0.43)

(0.07)

(4.49E-6)

(1.14E-6)

-0.4

0.1

0.5

1.3

2.2

(0.33)

(0.52)

(0.36)

(1.68E-5)

(1.97E-6)

0.5

0.6

0.7

0.8

0.6

(0.72)

(0.23)

(0.58)

(0.38)

(0.84)

0.3

0.3

0.3

1.3

2.1

(0.15)

(0.37)

(0.22)

(2.17E-5)

(7.62E-6)

2.9

2.9

3.6

4.7

3.7

(1.22E-6)

(1.34E-6)

(6.11E-7)

(3.01E-7)

(5.48E-7)

2.7

3.4

4.9

5.7

5.0

(3.77E-5)

(1.26E-5)

(6.18E-6)

(1.12E-6)

(2.05E-6)

Log2 fold change (q-value).
Q-value for differentially regulated genes ≤0.05.
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Figure 3.1. Diagram of the phosphate specific transport (Pst) system of E. coli O157:H7.
This system actively transports phosphate across the cytoplasmic membrane under P i
starvation conditions (Pi= inorganic phosphate; S=PstS protein that binds phosphate in
the periplasmic space; A and C are PstA and PstC transmembrane proteins; B= PstB
protein that is the ATP binding domain).
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Figure 3.2. Under phosphate limited conditions, PhoU is removed from the repressor
complex and PhoR undergoes autophosphorylation. Once this occurs, PhoR acts as a
histidine kinase and phosphorylate PhoB activates the Pho regulon by binding Pho boxes
and stimulating RNAP contact.
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Figure 3.3. Negative regulation of Pho operon by repressor complex comprised of Pi
bound PstS, PstABC, PhoU, and PhoR. By this mechanism PhoR is maintained in the
dephosphorylated repressor form, negatively regulating the Pho operon (Pi= inorganic
phosphate; S=PstS protein that binds phosphate in the periplasmic space; A and C are
PstA and PstC transmembrane proteins; B= PstB protein that is the ATP binding domain;
U=PhoU negative regulator; R=PhoR transmembrane sensor protein; B=PhoB phosphate
limited response regulator).
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Chapter 4
Increased Transcription of the Urease Operon of Escherichia
coli O157:H7 Exposed to 0.5% Sodium Benzoate Determined
with High-density Oligonucleotide Microarrays and Reversetranscriptase Polymerase Chain Reaction.
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Abstract
Sodium benzoate is a widely used food antimicrobial in drinks and fruit juices.
Understanding gene regulation in E. coli O157:H7 under antimicrobial stress is critical to
enable the design of appropriate control strategies. High-throughput novel technologies
such as microarrays enable the study and characterization of gene expression.
Microarrays were used to determine the transcriptional response of E. coli O157:H7
after exposure to 0.5% sodium benzoate.
Stationary phase E. coli O157:H7 grown in 150 ml Luria-Bertani broth (LB) was
exposed to 0 (control) and 0.5% sodium benzoate. Each treatment was duplicated,
sampled at 0 (immediately after exposure), 5, 15, 30, and 60 min. Total RNA was
extracted and analyzed with E. coli 2.0 Gene Chips.Differentially regulated genes
(positive-false discovery rate < 0.05) were determined using the R-MAANOVA
(microarray analysis of variance) package.
Microarray analysis revealed that all genes in the urease operon were upregulated > 2-fold (linear-scale) after 60 min exposure to sodium benzoate. The urease
operon is composed of three structural genes, ureA, ureB, and ureC, and four accessory
genes, ureD, ureE, ureF, and ureG.
Urease catalyzes the hydrolysis of urea to ammonia and carbon dioxide, and is
one mechanism by which microorganisms survive in acidic environments. Ammonium
ions accumulate in the surrounding environment, effectively mediating a rise in pH. In
this study, exposure of E. coli O157:H7 to sodium benzoate in a neutral pH environment
109

resulted in an increase in transcription of the entire urease operon. Understanding
adaptations of E. coli O157:H7 after exposure to antimicrobials is essential to better
understand and implement methods to inhibit or control its survival in foods.
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Introduction
E. coli O157:H7 is a member of the enterohemorrhagic E. coli (EHEC) and causes
hemorrhagic colitis in humans. The symptoms of an E. coli O157:H7 infection generally
include severe abdominal cramps and diarrhea (often times bloody), which can lead to
death. In children under the age of five, infection can lead to a complication known as
hemolytic uremic syndrome (HUS), resulting in red blood cell destruction, renal failure,
and central nervous system complications (37). E. coli O157:H7 can cause disease at a
low infectious dose (10 - 100 cells) (29). This can be attributed to the tolerance of this
bacterium to low pH, which allows passage through the stomach and colonization in the
intestinal tract (29). E. coli O157:H7 has been linked as the causative agent in outbreaks
associated with unpasteurized apple and orange juice, and experimental data
demonstrate the tolerance of E. coli O157:H7 to acidic environments (3, 7, 30, 42).
While it is very hard to quantify the impact foodborne illnesses have in the United
States, it has been estimated that foodborne disease causes 76 million illnesses annually
and approximately 5,000 fatalities (28). There were 16,614 laboratory-confirmed cases
of foodborne illness from FoodNet participants in 2005 (~15% of the United States
population), and E. coli O157:H7 was the causative agent in 2.8% of these cases (2). The
CDC estimates that there are 73,000 cases of E. coli O157:H7 annually, leading to an
estimated 2,100 hospitalizations in the United States (6). It has been estimated that the
cost of EHEC infections was $405 million dollars in 2003 (16).
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The well-described virulence factors of E. coli O157:H7 include stx1, stx2, and
eaeA (23, 40). Shiga toxins are composed of two subunits. The B-subunit binds
glycolipids in the host, and the A-subunit inhibits protein synthesis via disruption of
ribosomal RNA (1). Shiga-toxins may cause hemorrhagic colitis, hemolytic uremic
syndrome (HUS), thrombocytopenia, hemolytic anemia, and renal failure (22). The gene
eaeA in enterohemorrhagic E. coli produces intimin, a 97-kDa protein that plays a role in
attachment onto and effacement of microvilli of the small intestine (10, 15, 26, 27, 46).
Sodium benzoate is a food additive commonly used in acidic beverages due to its
relatively low pKa (4.2) and increased solubility (compared to benzoic acid). This
compound is generally recognized as safe and may be added at concentrations up to
0.1% in foods (21 CFR 184.1733).
A general mechanism of inhibition for weak-acids starts with diffusion of the
undissociated compound through the cell membrane by passive diffusion. Once inside
the cell, the higher pH causes dissociation of the acid and lower intracellular pH i and
inhibition of membrane-bound transport (5). Eklund (11) determined that uptake
inhibition contributed to growth inhibition, but did not seem to completely explain this
phenomenon. Eklund (14) found that ΔpH (pH difference) was eliminated by sorbic acid
as well as methyl and butyl paraben, whereas the membrane potential (Δψ) was
maintained (13). This indicates more than simple inhibition of the proton motive force,
since the membrane potential maintained would allow for uptake of essential
compounds for cellular maintenance. It has been determined that dissociated weak
acids also contribute a small portion to growth inhibition, which cannot be explained by
112

the effects of pHi(12). Sorbic acid, sorbic alcohol and sorbic aldehyde have been found
to cause similar levels of inhibition, demonstrating a mechanism of inhibition other than
a weak acid effect (45). Bracey and others (4) found that pHi was not altered in
Saccharomyces cerevisiae exposed to sorbic acid. However, a higher ADP/ATP ratio was
found indicating that the cell was expending energy to maintain pHi (4), and this
expenditure of ATP was theorized to decrease cellular growth.
Membrane disruption has also been attributed as a mechanism of inactivation by
sorbic acid (4, 45). Krebs and et al. (25) observed a reduction in phosphofructokinase
activity in Saccharomyces cerevisiae exposed to sorbic acid (25). The disruption of
glycolysis was thought to be caused by a decrease in pHi that decreased the enzymatic
activity of phosphofructokinase. Nitrogen starvation and benzoic acid treatment inhibit
growth of Saccharomyces cerevisiae. However, when used in combination, they are
cytocidal (18). It was found that benzoic acid inhibited the break-down of cytosolic
compounds to form amino acids and nucleotides necessary for growth and survival (18).

Escherichia coli O157:H7 Urease Operon
Escherichia coli O157:H7 is known to produce urea when degrading arginine to
putrescine (32, 33). Urease (EC 3.5.1.5) catalyzes the reaction of urea into two
molecules of ammonia and carbon dioxide (31). The liberated ammonia results in
increased pH of the surrounding environment. Escherichia coli O157:H7 EDL933
genomic sequence contains an O-island with two urease gene clusters (ureDABCEFG)
(38). Urease is composed of three structural proteins, UreA, UreB, and UreC, as well as
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four accessory proteins, UreD, UreE, UreF, and UreG (31). This enzyme could give
enterohemorrhagic E. coli (EHEC) the ability to neutralize acidic environments and allow
for survival in acidic food products as well as support survival in the gastrointestinal
tract.
When studying the presence of the urease gene clusters in E. coli O157:H7
isolates, it was found that among serotype O157:H7 isolates (n= 59), 98% contained all
genes in the urease operon(17). In contrast, none of the genes in the urease operon
were present in sorbitol-fermenting O157:NM (non-motile) isolates (n=82) (17).
However, among O157:H7 isolates found to have the urease operon, only one was
found to have urease activity when evaluated with Christensen’s agar or with the API
20E system; in this isolate, elevated levels of ammonia could be were detected (17).
When evaluating nine isolates of serotype O55:H7, from which E. coli O157:H7 has been
theorized to have diverged, none contained genes in the urease operon (17).
Similarly, Orth et al.(35) studied the distribution of ureC among 202 EHEC that
encompassed 61 serotypes. It was found that all O157:H7 and O157:NM (n=72) that
displayed the typical non-sorbitol fermenting phenotype possessed the ureC gene (35).
However, all sorbitol fermenting O157:NM isolates (n=8) were negative for ureC (35).
All isolates containing ureC were also found to contain all genes in the urease
operon(35). When the ureC isolates were evaluated for urease production in urease
degradation broth, only 3.4% showed urease activity (35). The nucleotide sequence of
all urease genes present in ten O157:H7 isolates studied were found to have ≥ 99%
homology (35). These data indicate that the urease operon was acquired by O157:H7
114

relatively recently and possibly through horizontal gene transfer or gene loss since both
O55:H7 and sorbitol fermenting O157:NM strains lack the urease gene cluster, and
although many E. coli O157:H7 isolates contain the urease operon, it is not commonly
expressed under normal culture conditions.
Nakano et al.(34) examined urease production by E. coli O157:H7 Sakai in various
culture media, pH, temperatures, and nutrients via ammonia production without any
success at stimulating urease production. When further examining 120 EHEC isolates
for urease activity, two isolates were identified as being urease positive (34). All isolates
were determined to have a urease operon of similar size (4940 bp), and the nucleotide
sequence was similar for a urease positive strain compared to the Sakai strain except for
a slightly longer open reading frame in the ureD gene of the urease positive isolate (34).
It was revealed that the Sakai strain as well as all urease negative EHEC isolates
examined (n=158) had a premature stop codon for ureD compared to that of the urease
negative isolate. When the ureD gene of a urease positive EHEC was transformed into
the Sakai strain urease production was detected(34). These data indicate that the
premature stop codon in UreD plays a role in urease production in vitro.
When attempting to stimulate urease production in E. coli O157:H7 strain
EDL933, urease could not be detected using Christensen’s agar, enzymatic assays, or
immunoblotting techniques targeting UreC and UreD (19). However, when nonpathogenic E. coli DH5 was transformed with the EHEC ure gene cluster, urease was
detected via enzymatic activity (19). This demonstrated that the urease genes present
in the EDL933 strain were functional, but failed to be expressed under multiple culture
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conditions. It is interesting that the ureD nucleotide sequence in strain EDL933 is
identical to Sakai (34). When Nakano et al.(34) transformed the Sakai ureD gene into E.
coli DH5 . urease was detected. The authors believe that the amber suppressor
phenotype of DH5 played a role in read-through of the premature stop codon. Heimer
et al.(19) determined that a trans-acting factor was inhibiting urease transcription in
EHEC. These authors also identified three Fur-like (ferric-uptake regulator) recognition
sites upstream of ureA and ureD (19). In this study, urease production was detected in
two other EHEC strains (IN1 and MO28), and a Δfur background greatly diminished the
urease activity of these strains (19). This research indicated that Fur, as well as other
unidentified trans-acting factors, plays a role in regulating the expression of urease in
EHEC.

Materials and Methods
Escherichia coli O157:H7
Escherichia coli O157:H7 strain EDL 933, obtained from the National Food Safety
and Toxicology Center at Michigan State University, was used for this study. Cultures
were grown in 125 ml Luria-Bertani broth (LB; Difco, Becton Dickinson Microbiology
Systems; Franklin Lakes, NJ) at 37˚C for 24 h, and transferred a minimum of three
successive times at 24-h intervals before use. The entire volume of stationary-phase
cells were centrifuged at 8000 x g for 10 min at 4˚C. The cell pellet was resuspended in
LB containing 0 (control) or 0.5% (w/v) sodium benzoate (Fisher Scientific; Fair Lawn,
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NJ). At every sampling time, cell counts were determined by surface plating on sorbitol
MacConkey Agar (SMAC; Difco, Becton Dickinson Microbiology Systems; Franklin Lakes,
NJ).

Experimental Design
A completely randomized design with repeated measures was utilized to study
the effects of exposuring E. coli O157:H7 to sodium benzoate. The control (0%) and
treatment (0.5%) sodium benzoate conditions were replicated once and sampled over
five time points [0 (immediately after exposure), 5, 15, 30, and 60 min].

Total RNA Isolation
The RNeasy Mini Purification Kit (Qiagen; Valencia, CA) was utilized to extract
total RNA from E. coli O157:H7. 1.2 ml RNAlater Stabilization Reagent (Qiagen; Valencia,
CA) was combined with 0.6 ml E. coli O157:H7. RNAlater immediately stabilizes RNA to
help safeguard against degradation of mRNA. After 10 min at room temperature, the
mixture was centrifuged at 8000 x g for 10 min under refrigeration (Eppendorf 5417C;
New York, NY). The supernatant was decanted and the bacterial pellet was stored at 70˚C until further processed (approx. 2-10 hr).
100 µl tris-EDTA buffer (10 mM Tris-Cl, 1 mM EDTA, ph 8.0; Promega; Madison,
WI) containing lysozyme (3 mg/ml; Sigma-Aldrich; St. Louis, MO) was added to each cell
pellet. The pellet was thoroughly mixed and incubated at room temperature for 10 min.
This disrupts the cell wall and membrane and allows for extraction of RNA. 350 µl of
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buffer RLT was combined with the tris-EDTA suspension to further lyse bacterial cells.
Buffer RLT contains guanidine thiocyanate which aids in denaturing proteins and
effectively inactivates ribonucleases to preserve RNA quality. The total volume was
combined with 250 µl of 200 proof ethanol (Aaper Alcohol; Shelbyville, KY) to solubilize
the cell lysate, and the entire sample was transferred to the RNeasy Mini spin column in
a collection tube and centrifuged at 8000 x g for 15 sec at room temperature (Sorvall
Biofuge Pico; Kendro, Germany). The silica-based membrane efficiently binds up to 100
µg of RNA longer than 200 bases. The collection tube and eluate were discarded and
the spin column was placed in a new collection tube. 700 µl of buffer RW1 was applied
to the column, centrifuged, and flow-through was discarded as described previously.
RW1 also contains guanidine thiocyanate to help disrupt protein structure and ethanol
to solubilize and remove other cellular material. Twice, 500 µl of buffer RPE was applied
to the spin column allowing 5 min prior to centrifugation at 8000 x g for 15 sec. Ethanol
also is a constituent of RPE and serves a primary role of removing residual salts from
previous buffers. The spin column was placed in a 1.5 ml collection tube that was used
for long-term storage. In order to elute RNA from the spin column, 30 µl of RNase-free
water was applied directly to the membrane and centrifuged at 8000 x g for 15 sec. Ten
RNA samples were extracted for each treatment and replicate (40/time point). The ten
samples were pooled and divided into aliquots to remove variation in RNA
concentration from differing RNA extraction efficiencies. The RNA eluate was stored at 80˚C until evaluated for quantity, quality, and purity.
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Evaluation of RNA Quality, Quantity, and Purity
The NanoDrop spectrophotometer (NanoDrop Technologies; Wilimington, DE)
was utilized to determine absorbance of samples at 230, 260, and 280 nm. RNA
concentration is determined by absorbance at 260 nm (1 absorbance unit=40 µg/ml).
The A260 / A280 and A260 / A230 ratios indicate contamination (e.g. proteins, ethanol, salts)
and should fall between 1.8 to 2.1. Lower ratios may interfere with down-stream
processing of RNA for microarrays and RT-PCR.
In addition to spectrophotometric analysis, RNA samples were also analyzed for
quality using the Agilent 2100 electrophoresis bioanalyzer (Agilent Technologies; Santa
Clara, CA). This analysis allows for visualization of 23S and 16S rRNA bands, assuring
that there is no degradation of RNA and the absence of chromosomal DNA.

High Density Oligonucleotide Microarray Analysis

cDNA Synthesis
The Affymetrix protocol for GeneChip prokaryotic processing was followed for
this study. In vitro synthesized polyadenylated transcripts for Bacillus subtilis
(Affymetrix; Santa Clara, CA) were diluted 1 x 10-2.5 and spiked-into the primer annealing
master mix at a volume of 2µl. This “spike-in” is evaluated in the final processing of the
microarray as a means of monitoring the assay sensitivity and performance from the
beginning to final stages. Ten micrograms of total RNA was added to the primer
annealing mastermix (final concentration 0.33µg/µl). Ten microliters of random primers
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(Invitrogen; Carlsbad, CA) at a concentration of 75 ng/µl (final concentration 25ng/µl)
and nuclease-free water (Ambion; Austin, TX) were added to bring the entire master mix
volume to 30 µl. The following conditions were utilized to anneal random primers: 70˚C
for 10 min; 25˚C for 10 min; chill to 4˚C (PCR Sprint Thermal Cycler; Thermo Fisher
Scientific; Waltham, MA)
The RNA/primer master mix was centrifuged at 5000 x g for 1 min at room
temperature. The SuperScript first-strand synthesis system (Invitrogen; Carlsbad, CA)
reagents and SUPERase-In (Applied Biosystems; Foster City, CA) were combined with the
30µl RNA/primer master mix as described in Table 4.1. All tables and figures are found
in an appendix located at the end of the chapter. The cDNA synthesis conditions were:
25˚C for 10 min; 37˚C for 60 min; 42˚C for 60 min; 70˚C for 10 min; chill to 4˚C.
Remaining RNA was degraded with the addition of 20µl/rxn of 1N NaOH and incubated
at 65˚C for 30 min. The reaction was neutralized with the addition of 20µl/rxn of 1N
HCl.

Purification and Quantitation of cDNA
The MinElute PCR Purification Kit (Qiagen; Valencia, CA) was utilized to clean up
the cDNA synthesis product prior to further microarray processing. Five volumes of
buffer PB were added to the cDNA product, placed on a MinElute spin column, and
centrifuged at room temperature at 5000 x g for 1 min. Eluate was discarded and 750 µl
of buffer PE was applied to the column and centrifuged as described above. Residual
ethanol from the buffer PE was allowed to evaporate from the spin column prior to
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eluting cDNA with 12 µl buffer EB. The resulting purified product was analyzed as
previously described with the NanoDrop spectrophotometer to determine cDNA yield.

cDNA Fragmentation
Purified cDNA (3µg) was combined with 10X One-Phor-All buffer (GE Healthcare;
Buckinghamshire, England), DNAse I (0.6 U/µl; GE Healthcare; Buckinghamshire,
England), and nuclease-free water as described in Table 4.2. The reaction was held at
37˚C for 10 min followed by 98˚C for 10 min to inactivate DNAse I.

Terminal Labeling
The GeneChip DNA Labeling Reagent (Affymetrix; Santa Clara , CA) was used to
label the 3’ termini of the fragmented cDNA products with biotin. Volumes of reagents
utilized in this reaction are listed in Table 4.3. The reaction was held at 37˚C for 60 min
followed by addition of 2µl of 0.5M EDTA (Invitrogen; Carlsbad, CA) to arrest the
labeling reaction by inactivating the terminal deoxynucleotidyl transferase (Promega;
Madison, WI) .

cDNA Target Hybiridization
The biotin labeled, fragmented cDNA was added to the hybridization master mix.
Table 4.4 describes the reagents utilized in this reaction. The B2 control oligo acts as a
hybridization control and allows for alignment of the GeneChip microarray in the
analysis software. Herring sperm DNA was used as a blocking agent during hybridization
to prevent improper annealing of cDNA fragments with probes.
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The E. coli Genome 2.0 Array (Affymetrix; Santa Clara, CA) was allowed to
equilibrate to room temperature. This GeneChip allows the detection of transcripts
from E. coli K12 (MG1655) as well as a uropathogenic strain (CFT073) and two
enterohemorrhagic strains of the serotype O157:H7 (EDL933 and Sakai). 200 µl of the
hybridization solution was added to the GeneChip and the array was placed in the
hybridization oven (Affymetrix; Santa Clara, CA) at 45˚C, 60 RPM for 16 hr. The
hybridization solution was then removed and replaced with 80 µl of non-stringent wash
buffer (wash buffer A; 6x SSPE, 0.01% Tween-20) and the GeneChips were stored at 4˚C
until washed and stained.

GeneChip Washing, Staining, and Scanning
The GeneChip Operating Software (GCOS; Affymetrix; Santa Clara, CA) controlled
the operation of the Fluidics Station 450 (Affymetrix; Santa Clara, CA). Streptavidin
phycoerythrin (SAPE; Table 4.5) was loaded into the first and third 1.5 ml staining vial in
the fluidics station, while the second stain vial contained an antibody solution mix (Table
4.6). The Mini_prok2v1_450 fluidics station protocol (Table 4.7) was followed for
washing and staining hybridized biotin labeled cDNA fragments. The GeneChip Scanner
3000 (Affymetrix; Santa Clara, CA) and GCOS were used to produce .cel files which
contained the fluorescence intensity data for a probe. Each target sequence contains 11
25-oligomer probes that are spread throughout the entire sequence (perfect match) as
well as 11 25-oligomer probes that match the target with the exception of the 13 th
nucleotide which is a mismatch to the desired target sequence and indicates non122

specific binding (mismatch). Fluorescence data for these 22 probes are combined into a
probe set for further analysis.

Statistical Analysis of Microarray Data
The R programming environment (v 2.5.1) was used for all microarray data
analysis. First, GCOS generated CEL files, CDF file, and probe file were uploaded into the
GCRMA package (v 2.0.0) (48). This program normalizes microarray data by using
Affymetrix probe sequence affinities based on the specific probe sequence in addition to
normalization from background noise also used in robust multiarray average (RMA)
analysis. Following normalization with the GCRMA package, the intensities for probe
sets were compared among treated and control cells across all time points using the
microarray analysis of variance package (MAANOVA; v 1.4.1) (47). Next, the positive
false discovery rate (pFDR; q-value) was determined to differentiate genes which were
significantly regulated in response to exposure of sodium benzoate (q-value; v 1.10.0)
(9). A subset of genes which were differentially regulated (q < 0.05) were determined
and used for further analysis.

Selection of genes for validation with Real-time one-step reversetranscriptase PCR (rt-RT-PCR)
Three tools were used to analyze microarray results so a subset of significantly
regulated genes could be selected for further validation with rt-RT-PCR. The Pathway
Tools Omics Viewer (SRI International; Menlo Park, CA) was used to visualize metabolic,
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transport, and signaling pathways in addition to proteins integral to the membrane and
periplasm specific to E. coli O157:H7 (36). The output would link through pathway tools
to BioCyc (SRI International; Menlo Park, CA) and give further insight to pathways,
molecular interactions, proteins, and genes. However, the database specific to E. coli
O157:H7 was computationally generated with very little curation based on findings in
current literature. When the pathways of interest were homologous to E. coli K-12, the
EcoCyc database which receives extensive literature based curation was utilized to gain
further insight to functional and regulatory information for a pathway of interest (24).

Selection of housekeeping genes for standardization of rt-RT-PCR
Secondary validation of microarray data was achieved with the Pfaffl method which
incorporates the efficiency of a PCR reaction in addition to the difference in Ct values
between the treated and control samples (39). The equation below shows how the
ratio is calculated to determine increased or decreased levels of target mRNA when
comparing the control and treated sample. This difference is also standardized with one
or more reference or housekeeping genes which are expressed at the same level
between the control and treatment.

124

From the microarray data, genes were selected which had a highly non-significant qvalue (q>0.98). Genes were excluded if their function was not known, or if there was a
high amount of variability between replicate microarrays. rt-RT-PCR was used to
validate these genes as appropriate housekeeping markers for microarray validation.
Each sample was run in triplicate and there were a total of six cycle threshold values for
each treatment within each time point. A completely randomized design with repeated
measures was used to assure there was no difference in cycle threshold values within
each time point (p>0.05; SAS v9.1; Cary, NC). This methodology helped to assure that
there was no difference in mRNA expression between treatments.

Nucleic acid amplification
rt-RT-PCR was performed on RNA extracts as a means of microarray validation.
SuperScript™ III Platinum® SYBR® green one-step rt-RT-PCR kit reagents (Invitrogen;
Carlsbad, CA) were utilized in 25 µl reactions (2.5 µl serially-diluted RNA, 12.5 µl SYBR®
green reaction mix, 1 µl BSA, and 0.5 µl SuperScript™ III reverse transcriptase/Platinum®
Taq Mix, 0.025 µg forward and reverse primers for the target gene, and the remainder
RNase-DNAse free water). Primer sequences (Table 4.8) were developed using Beacon
Designer 4.0 software (Premier Biosoft International; Palo Alto, CA). The Bio-Rad My
iQ™ single color real-time PCR detection system (Hercules, CA) was used to conduct rtRT-PCR using the following parameters: 1) conversion of mRNA to cDNA, 35 min at 50˚C;
2) denature reverse-transcriptase, 2 min at 94˚C; 3) denature template, 30 sec at 94˚C;
annealing of primers, 45 sec at 55˚C; and extension with Taq polymerase, 30 sec at 72˚C;
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repeated 40 times; 4) final extension, 5 min at 72˚C; 5) melt curve. All rt-RT-PCR
experiments were conducted in triplicate for each RNA sample and a negative control
was included for each assay.

Results and Discussion
Microarray analysis revealed a large number of genes that were significantly
regulated in response to 0.5% sodium benzoate. As shown in Table 4.9, the number of
genes which were differentially regulated increased with exposure time, and after 60
minutes of exposure to sodium benzoate 1707 genes were found to be differentially
expressed (q≤0.05).
Ontology analysis allowed for insight to genes which responded to sodium
benzoate exposure based on biological process, molecular functions, or cellular
components. Genes categorized into biological processes were the greatest to respond
across all time points (Table 4.10). There were a large number of genes associated with
biological process nodes which responded quickly to sodium benzoate exposure (0 and
5 min). Most of these nodes were associated with metabolic activities such as protein
biosynthesis. Genes associated with the ribosome and RNA binding were also found for
these early time point. Genes involved in protein translation respond very early to the
stimulus of sodium benzoate.
There was a rapid decline in significant ontology categories at 15 min, but an
increase was observed for 30 and 60 min. At 15 min the biological process nodes
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represented genes that responded to unfolded proteins and alcohol metabolism.
Significant cellular component nodes were found for genes involved with the cell
membrane. Genes were also found to be regulated that responded to the molecular
functions of carbohydrate transport and nickel ion binding.
Genes associated with molecular functions and cellular components had a
greater response to sodium benzoate after 30 and 60 min of exposure. Molecular
function nodes which had increased expression at these time points pertained to RNA
and ATP binding activity as well as carbohydrate transport. The significant cellular
component nodes at these times were oriented around the ribosome and products
which were integral to the membrane or part of the inner membrane. Biological
process nodes associated with a response to chemical and antibiotic stimuli were found
after 15 min of exposure and continued until 60 min. Many of these genes are
components of efflux pumps as well as transcription regulators, such as marA, the
multiple antibiotic resistance regulon activator.
Ontology analysis gives insight to expression of genes that are found in E. coli K12. While there is large amount of overlap between the genomes of K-12 and O157:H7,
genes specific to O157:H7, termed O-islands, may contribute to this pathogen’s ability
to survive adverse environments as well as cause illness (38). The urease operon was
one such O-island which was found to have an increase in mRNA transcription when E.
coli O157:H7 was exposed to sodium benzoate for 60 min. This enzyme could give
enterohemorrhagic E. coli (EHEC) the ability to neutralize acidic environments and allow
for survival in acidic food products as well as support survival in the gastrointestinal
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tract. Therefore, further validation of the microarray results for the structural proteins
of the urease operon with rt-RT-PCR were conucted.
The glutamine synthetase adenyltransferase (glnE) gene catalyzes the addition of
AMP to a subunit of glutamine synthetase. PspF is a σ54 dependent transcriptional
activator that is cis-acting on the phage-shock protein (psp) operon and has been found
to be constitutively expressed (20, 21). No significant differences were found in Ct
values for these genes across treatments within time points for either gene (p > 0.05).
Therefore, glnE and pspF were utilized as the housekeeping genes by which rt-RT-PCR
assays were normalized in the Pfaffl method.
The log2 fold-change between 0.5% sodium benzoate treated E. coli O157:H7
cells and that of the control conditions is shown in Table 4.11. The structural genes of
the urease operon (ureA,ureB, and ureC) were validated with rt-RT-PCR. All structural
genes had increased expression when cells were exposed to 0.5% sodium benzoate for
60 min (Table 4.11). Expression of ureA was slightly higher in the rt-RT-PCR analysis
compared to the microarray data (3.1 versus 2.6 log2 fold-change, respectively).
However, comparative fold-change values for ureB and ureC were slightly lower for the
rt-RT-PCR analysis compared to those obtained from microarray analysis (Table 4.11).
This indicates that the production of urease may increase in response to sodium
benzoate since the transcription of the genes which compose the three subunits of the
apourease enzyme are up-regulated.
The accessory genes of the urease operon were not validated with rt-RT-PCR, but
the fold-change values from microarray analysis are shown in Table 4.12. They follow a
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similar trend in expression to the structural genes of urease. All accessory protein genes
have a > 4-fold increase in transcription (linear scale), but like ureB and ureC, these
values may be slightly inflated in the microarray analysis. Urease is a nickel-containing
enzyme that requires these accessory proteins to interact with the structural subunits
UreA, UreB, and UreC. The homologous proteins of Klebsiella aerogenes have been
studied to determine the function of urease accessory proteins; UreD, UreF, and UreG
interact with the structural subunits while UreE binds intracellular Ni2+ (8, 43, 44). All
accessory proteins interact to promote the transfer of nickel to the metallocenter of the
enzyme which is necessary for urease activity (8, 19, 43, 44).
It was noted when conducting analysis in the Omics Viewer that the nickel
transporter proteins of E. coli O157:H7 were down-regulated in sodium benzoate
treated cells (NikABCDE; Table 4.13). However, this down-regulation was lessened with
time and the activator of this protein, Fnr, was increased with exposure time (Table
4.13). Fnr is known to activate the nickel transporter operon in the absence of oxygen
since nickel is required during anaerobic growth for NiFe-hydrogenase synthesis (41).
However, both cultures were grown in a similar manner with shaking to increase culture
aeration. Therefore, this mechanism should not playing a large role in fnr transcription.
Most likely, the increased transcription of fnr observed in this study is in response to cell
need for nickel for adequate urease production.
Since the production of functional urease by E. coli O157:H7 has been
questioned in previous research (17, 19, 34, 35), the maintenance of an alkaline
environment in urea broth and agar was studied for further validation of these findings.
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First, cells were grown in LB with and without 0.5% sodium benzoate for 24 hr, after
which they were surface plated onto urea agar. E. coli O157:H7 on urea agar did not
produce an alkaline reaction, indicating that urease was not produced under either of
these conditions. However, when stationary phase E. coli O157:H7 was inoculated into
urea broth with and without 0.5% sodium benzoate for 24 hr, an alkaline environment
was maintained in urea broth containing 0.5% sodium benzoate, and an acidic
environment was produced in the control (Figure 4.1). This indicates that E. coli
O157:H7 responds rapidly to the stimulus when producing urease, and once this
stimulus is removed urease is no longer produced.
When examining fur expression in the microarray data, a slight increase in
transcription was seen among all time points for sodium benzoate treated cells (data
now shown); there was a 1.4-1.8 fold increase (linear scale) in transcription for fur. This
supports the findings that Fur can help stimulate production of urease, but there is also
a secondary trans-acting factor that controls the regulation of this operon (19).
This indicates that sodium benzoate allows E. coli O157:H7 to maintain an
alkaline environment that is not achieved otherwise. This supports data from microarray
and rt-RT-PCR results and indicates that increased transcription of urease mRNA
produces a functional enzyme that can help to neutralize acidic environments.
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Conclusions
These data support previous research that E. coli O157:H7 does not express
urease constitutively, but requires stimulation of this operon from the environment.
Exposure to sodium benzoate in a neutral pH (6.8) resulted in increased transcription of
structural and accessory urease genes. Analysis of urease production in urea broth
confirmed that a functional enzyme was produced under these conditions that
counteracted the effects of acid production in a culture system. This indicates that
research which concluded that urease genes were not functional due to lack of
expression may have simply not been applying the appropriate stress to simulate
expression of this enzyme. Further research can focus on exposure to sodium benzoate
followed by exposure to low pH and further examination of the resulting transcriptome
with respect to adaptation mechanisms as well as virulence factors in EHEC. Further
studies will be focused on isolating urease structural proteins in sodium benzoate
treated cells for further validation of this finding.
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Table 4.1. cDNA synthesis master mix components.
Reagent
Volume per reaction (µl)
5X First-strand cDNA Buffer

12

100 mM DDT

6

10 mM dNTP Mix

3

SUPERase-In (20 U/µl)

1.5

Superscript II (200 U/µl)

7.5

RNA/primer Hybiridization

30
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Table 4.2. cDNA fragmentation master mix components.
Reagent
Volume per reaction (µl)
10x One-Phor-All Buffer

2

cDNA

15

DNAse I

1.8

Nuclease Free Water

1.2
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Table 4.3. Terminal labeling of cDNA fragments with biotin master mix components.
Reagent
Volume per reaction (µl)
5x Reaction Buffer

10

GeneChip DNA Labeling Reagent, 7.5mM

2

Terminal Deoxynucleotidyl Transferase

2

Nuclease Free Water

16

Fragmented cDNA Product

20
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Table 4.4. Biotin labeled cDNA hybridization master mix components.
Reagent

1

Volume per reaction (µl)

2x Hybirdization Buffer1

40

3 nM B2 Control Oligo

1.3

10 mg/ml Herring Sperm DNA

0.8

50 mg/ml BSA

0.8

100% DMSO

6.2

Nuclease Free Water

5.9

Fragmented and Labeled cDNA Product

25

200 mMMES, 2M [Na+], 20 mM EDTA, 0.01% Tween-20
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Table 4.5. Streptavidin phycoerythrin (SAPE) staining solution components.
Reagent
2x MES Stain Buffer

Volume per
Reaction (µl)
600

Final Concentration
1x

50 mg/ml BSA

48

2 mg/ml

1 mg/ml Streptavidin
Phycoerythrin
Nuclease Free Water

12

10 µg/ml

540
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Table 4.6. Antibody solution mix components.
Reagent

Volume per
reaction (µl)
300

Final
concentration
1x

50 mg/ml BSA

24

2 mg/ml

10 mg/ml Goat IgG

6

0.1 mg/ml

0.5 mg/ml Anti-streptavidin Antibody (goat),
Biotinylated
Nuclease Free Water

6

5 µg/ml

2x MES Stain Buffer
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540

Table 4.7. Mini_prok2v1_450 fluidics station program.
Step
Post Hyb Wash #1

Temperature (˚C)
30

Post Hyb Wash #2

50

1st Stain

35

2nd Stain

35

3rd Stain

35

Final Wash

35

Description
10 cycles of 2 mixes/cycle with Wash
Buffer A
4 cycles of 15 mixes/cycle with Wash
Buffer B
Stain the probe array for 5 min in SAPE
Stain the probe array for 5 min in
Antibody Solution Mix
Stain the probe array for 5 min in SAPE
15 cycles of 4 mixes/cycle with Wash
Buffer A
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Table 4. 8. Primers for rt-RT-PCR assays to determine mRNA expression of ureA, ureB,
ureC, glnE, and pspF in E. coli O157:H7 when exposed to 0 and 0.5% sodium benzoate.
Primer
Sequence (5′→3′)
ProductTm (˚C) Product size (bp)
ureAF

CTTAACTATCCCGAATCC

ureAR

TTCTGGTATGCCTTCC

ureBF

GCAGTATTATCGTTGAAAATC

ureBR

AGCCTCTTGCCTTCTGG

ureCF

CGGGTTGCTGGGTAAAG

ureCR

CGGATTGGTTGAGGAAGG

glnEF

GGATGGCTTCGTCTATCG

glnER

GAGCTGGAACACCTGAAC

pspFF

TCTGCTGGATTCCGAACTG

pspFR

GCATACCAACCGCACATTC

146

86.5

138

83.5

111

86.5

328

88

361

86.5

226

Table 4.9. Number of differentially regulated genes over time (q<0.05) when E. coli
O157:H7 is exposed to 0.5% sodium benzoate.
Number of genes
Time
differentially
(min)
regulated
270
0
5

458

15

564

30

795

60

1707
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Table 4.10. Number of significant ontology nodes within biological process, cellular
components, and molecular function as determined with JProGO.
Biological
Cellular
Molecular
Time
p-value
Process
Components
Function
51
8
11
5.1077E-4
0
5

57

0

3

5.1851E-4

15

4

2

6

1.0249E-4

30

14

10

13

2.7975E-4

60

32

15

26

6.3335E-4
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Table 4. 11. Increased transcription of ureA, ureB, and ureC mRNA (q<0.05) in E. coli
O157:H7 when exposed to 0.5% sodium benzoate for 60 min and analyzed with high
density oligonucleotide microarrays and validated with rt-RT-PCR.
Microarray log2
Microarray q-value
rt-RT-PCR log2
Target mRNA
fold-change
fold-change
ureA

2.3

1.66 E-6

3.1

ureB

2.0

8.41E-7

1.6

ureC

1.4

1.25 E-6

0.7
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Table 4. 12. Increased transcription of ureD, ureE, ureF, and ureG mRNA in E. coli
O157:H7 when exposed to 0.5% sodium benzoate for 60 min and analyzed with high
density oligonucleotide microarrays.
Microarray log2
Microarray
fold-change
q-value
Target mRNA
ureD
2.5
1.92 E-6
ureE

2.1

5.03 E-6

ureF

2.5

3.65 E-6

ureG

2.5

5.08 E-7
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Table 4.13. Transcription of nikA, nikB, nikC, nikD, nikE, nikR, and fnr mRNA in E. coli O157:H7 when exposed to 0.5% sodium
benzoate and analyzed with high density oligonucleotide microarrays.
Microarray log2 fold-change
Target
mRNA

5 min

nikA

-2.8

0.005

-4.3

0.001

-2.8

0.004

-0.5

0.0005

nikB

-2.0

0.003

-4.1

1.5E-5

-2.8

9.56E-5

-1.2

0.004

nikC

-2.3

0.005

-4.6

0.0001

-3.9

0.0003

-1.5

0.02

nikD

-2.1

0.001

-4.3

2.41E-5

-3.6

8.06E-5

-1.1

0.01

nikE

-1.9

0.0006

-3.2

1.61E-5

-2.9

4.77E-5

-1.3

0.003

nikR

-1.8

2.77E-5

-2.8

2.6E-6

-2.6

3.4E-6

-1.0

0.0004

fnr

0.4

0.06

1.1

2.16E-5

1.6

5.6E-6

2.1

1.7E-6

q-value

15 min

q-value
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30 min

q-value

60 min

q-value

Figure 4.1. Growth of E. coli O157:H7 in A) urea broth with B) 0.5% sodium benzoate and C) 0%
sodium benzoate. Red color indicates alkaline reaction.
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